{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":818,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":818,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"cde18f9d463e","filters":{"topic":"Protein Degradation and Inhibitors"}},"results":[{"id":"W2041535798","doi":"10.1038/nature09504","title":"Selective inhibition of BET bromodomains","year":2010,"lang":"en","type":"article","venue":"Nature","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4296,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; U.S. Public Health Service; Cancer Research UK; Wellcome Trust","keywords":"Bromodomain; BRD4; Epigenetics; Chromatin; BET inhibitor; Small molecule; Histone; Fusion protein; Chemistry; Binding site; Computational biology; Acetylation; Biology; Cell biology; Cancer research; Biochemistry; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.00277973780960531,"gpt":0.2342449400341446,"spread":0.2314652022245393,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006497683,0.00005615545,0.00005236287,0.0000253471,0.00002587524,0.000004376701,0.00005294,0.000780922,0.00002565653],"category_scores_gemma":[0.0001081425,0.00005099427,0.00004143749,0.00007082643,0.00003808392,0.000002458034,0.00002480036,0.0006076286,0.000003632283],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000002823065,"about_ca_system_score_gemma":0.00003208905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002957747,"about_ca_topic_score_gemma":0.00003279078,"domain_scores_codex":[0.9996346,0.00001383135,0.00007453172,0.0001251748,0.00007950335,0.00007241939],"domain_scores_gemma":[0.9996905,0.000002990201,0.00004572918,0.0001386613,0.00009436948,0.00002776635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00001739307,0.00002393502,0.0005018162,0.000004367555,0.000007318029,2.566759e-7,0.00001104113,3.70252e-7,0.9871519,0.0009676699,0.0107499,0.0005640668],"study_design_scores_gemma":[0.0002138144,0.00007038107,0.003315639,0.00000377439,0.000002623931,0.000003633766,0.000007073775,0.000003196821,0.9559126,0.0003150663,0.04009392,0.00005822177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994356,0.0001179509,0.0001206805,0.0002260783,0.0002134296,0.00008973676,0.00002015408,0.000007836605,0.004848145],"genre_scores_gemma":[0.9981602,0.00000847993,0.0007949911,0.0003336837,0.0002302986,0.000005067609,0.0001228234,0.000007115126,0.0003373762],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03123921,"threshold_uncertainty_score":0.6023185,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2123647733","doi":"10.1016/j.cell.2012.02.013","title":"Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family","year":2012,"lang":"en","type":"article","venue":"Cell","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1752,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada Research Chairs; Ontario Institute for Cancer Research; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Structural Genomics Consortium","funders":"Canada Research Chairs; Canadian Institutes of Health Research; Genome Canada; Wellcome Trust; GlaxoSmithKline; Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council of Canada; Pfizer; Eli Lilly and Company","keywords":"Bromodomain; Acetylation; Biology; BRD4; Histone; Computational biology; Genetics; Structural similarity; BET inhibitor; Epigenetics; Biochemistry; DNA; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01339970949480928,"gpt":0.2479835714959281,"spread":0.2345838620011188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008480897,0.00004855534,0.00006732243,0.00002682597,0.00005669561,0.00000381674,0.00005103562,0.00005200394,0.00003308149],"category_scores_gemma":[0.000007280519,0.00003630843,0.00006216197,0.00009102951,0.0000430229,0.00000298627,0.00004351388,0.00003046819,0.000001713453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005652954,"about_ca_system_score_gemma":0.000005367733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001618076,"about_ca_topic_score_gemma":0.000016926,"domain_scores_codex":[0.9996473,0.00003675069,0.0000887736,0.00008489668,0.00005230064,0.00009004424],"domain_scores_gemma":[0.9997449,0.000002138386,0.00005751176,0.0001424411,0.00002209757,0.00003093875],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000003396797,0.00001769039,0.007538232,0.000005200362,0.00002896569,2.065909e-8,0.00008463454,7.548463e-7,0.9914755,0.000008188914,0.000411397,0.0004260441],"study_design_scores_gemma":[0.000203975,0.00002165288,0.08100893,0.00000200508,0.0001101571,4.96252e-7,0.00008802332,0.0000205097,0.9132144,0.00005933877,0.005204985,0.00006550409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997623,0.0005945779,0.000191482,0.00001326667,0.00006704158,0.00005744831,0.00003505425,0.000002505494,0.001415584],"genre_scores_gemma":[0.9989017,0.00001324551,0.0001711956,0.00008955245,0.0000578669,0.000002564951,0.0001690483,0.000004224285,0.0005906291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07826106,"threshold_uncertainty_score":0.1480615,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003872705","doi":"10.1038/nrd4286","title":"Targeting bromodomains: epigenetic readers of lysine acetylation","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1245,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Bromodomain; Acetylation; BRD4; Epigenetics; BET inhibitor; Chromatin; Drug discovery; Lysine; Computational biology; Transcriptional regulation; Biology; Regulator; Histone; Chemistry; Cell biology; Biochemistry; Transcription factor; Amino acid; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01540294611039873,"gpt":0.3141765041191744,"spread":0.2987735580087757,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009916337,0.000567356,0.001941469,0.0001410429,0.00006598559,0.00004479105,0.0004827189,0.0009583144,0.00001997299],"category_scores_gemma":[0.0008552378,0.0004255206,0.001087695,0.0003367135,0.00009933938,0.0000171239,0.0001676688,0.0006352882,0.00003571998],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004812564,"about_ca_system_score_gemma":0.0002080509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003885905,"about_ca_topic_score_gemma":0.000004139433,"domain_scores_codex":[0.9967421,0.0006791621,0.0012964,0.0007044011,0.0002818403,0.0002960698],"domain_scores_gemma":[0.9975482,0.00004725096,0.001382009,0.0008506753,0.00008967543,0.00008219031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001103462,0.0000742636,0.000004175211,0.03018471,0.0001924774,0.000001112119,0.00001859708,0.00000678372,0.001150602,0.0001481694,0.03852904,0.929679],"study_design_scores_gemma":[0.0001404866,0.00004016954,7.180624e-7,0.008790512,0.0003518249,0.000006832638,0.000006812586,0.000002491191,0.0009686661,0.00001723763,0.9892536,0.0004206951],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002051543,0.996161,0.001415262,0.00003390808,0.0004776648,0.001400072,0.00006054744,0.00001247297,0.0004185937],"genre_scores_gemma":[0.0001033895,0.993428,0.0009581292,0.0001393292,0.0009364862,0.0001186922,0.002841446,0.00008048176,0.00139404],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9507245,"threshold_uncertainty_score":0.9998196,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2982554531","doi":"10.1038/s41573-019-0047-y","title":"Targeted protein degradation: expanding the toolbox","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":938,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"Wellcome Trust","keywords":"Drug discovery; Ubiquitin; Protein degradation; Computational biology; Proteasome; Toolbox; Proteolysis; Ubiquitin ligase; Chemical biology; Drug; Drug development; Bioinformatics; Computer science; Biology; Pharmacology; Cell biology; Biochemistry; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.02643913160446375,"gpt":0.3262636766066986,"spread":0.2998245450022348,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008938761,0.0006948092,0.001451815,0.00009906552,0.0001776455,0.0002322666,0.000904654,0.0009232158,0.00005149445],"category_scores_gemma":[0.0005402025,0.0003909177,0.001250222,0.0004324188,0.000080591,0.00003461132,0.0002279107,0.001240513,0.000250314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007990738,"about_ca_system_score_gemma":0.0004290921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003357185,"about_ca_topic_score_gemma":0.00000755672,"domain_scores_codex":[0.9967862,0.0007175608,0.0009299899,0.0008422871,0.0003431953,0.000380781],"domain_scores_gemma":[0.9975641,0.00004330732,0.000854127,0.001391754,0.0000686307,0.00007813257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001021656,0.00004529348,0.000001536621,0.01102592,0.0001638081,0.000002247146,0.000009579495,2.950671e-7,0.000365859,0.0004642649,0.09105336,0.8968576],"study_design_scores_gemma":[0.0001239321,0.00002858329,4.303269e-7,0.007752488,0.0002795301,0.00001895443,0.000009715139,3.112249e-7,0.00104485,0.00001101563,0.9902231,0.0005071094],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001727018,0.9926872,0.0001353027,0.000134611,0.0009731464,0.004446516,0.00009387123,0.00002188809,0.001490193],"genre_scores_gemma":[0.0000213537,0.9679706,0.000180437,0.0004078475,0.001285099,0.0007716367,0.002323214,0.00008670494,0.02695313],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8991697,"threshold_uncertainty_score":0.9998543,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2171613528","doi":"10.1038/nature13393","title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","year":2014,"lang":"en","type":"article","venue":"Nature","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":900,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institute of Neurological Disorders and Stroke; National Human Genome Research Institute","keywords":"Cyclin-dependent kinase 7; Cyclin-dependent kinase; Kinase; Transcription factor; Transcription (linguistics); Cancer research; Biology; Chemistry; Cell biology; Biochemistry; Cell; Cell cycle; Protein kinase A; Cyclin-dependent kinase 2; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.004797204971728208,"gpt":0.2364676590853878,"spread":0.2316704541136596,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001251334,0.00007793424,0.00006193323,0.00003466466,0.00003085287,0.00001109905,0.00004947379,0.0004527843,0.00002218806],"category_scores_gemma":[0.00003630925,0.00006387695,0.00002189043,0.00008828506,0.00001806253,0.000005599582,0.000008261061,0.0003221845,0.000001851734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001922046,"about_ca_system_score_gemma":0.00002502661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001479909,"about_ca_topic_score_gemma":0.00009983023,"domain_scores_codex":[0.9994601,0.00003942176,0.00009804653,0.000186045,0.0001108993,0.0001055056],"domain_scores_gemma":[0.9997772,0.000002305266,0.00004196632,0.00009903539,0.00005261636,0.00002687759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001000175,0.00002450317,0.002601057,0.00001651967,0.000005615992,2.879586e-7,0.00003678767,0.0003253666,0.98887,0.0001790596,0.004690127,0.003150659],"study_design_scores_gemma":[0.0009671269,0.0001655412,0.009724298,0.00006336531,0.000006262325,0.000002134817,0.00002599159,0.0007027514,0.8151603,0.00006362516,0.1729445,0.0001740834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942493,0.001328826,0.002415961,0.0009584959,0.0002387781,0.0002086406,0.000005898344,0.00001532379,0.0005787543],"genre_scores_gemma":[0.9978908,0.00005435149,0.0005611962,0.0005665732,0.0003849747,0.00002734235,0.0001210932,0.00001090994,0.000382759],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1737096,"threshold_uncertainty_score":0.3492287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2226721679","doi":"10.1038/nature16508","title":"Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer","year":2016,"lang":"en","type":"article","venue":"Nature","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":629,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"Congressionally Directed Medical Research Programs; National Human Genome Research Institute; National Cancer Institute; Dana-Farber/Harvard Cancer Center; Ludwig Center at Harvard; National Institutes of Health; Cancer Research UK; Natural Sciences and Engineering Research Council of Canada; U.S. Department of Defense; Princess Margaret Cancer Foundation; Cancer Prevention and Research Institute of Texas; Susan G. Komen for the Cure","keywords":"Bromodomain; BRD4; Triple-negative breast cancer; BET inhibitor; Chromatin; Cancer research; Breast cancer; Cancer; Epigenetics; Biology; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.003928327806201479,"gpt":0.251001048709911,"spread":0.2470727209037095,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002601584,0.0001094981,0.00009819998,0.00006915217,0.00003584245,0.00001209723,0.00009263098,0.0005192613,0.00002169495],"category_scores_gemma":[0.0003719852,0.00007826955,0.00002738672,0.0001521072,0.00005036192,0.000006875978,0.00006066137,0.0002346411,0.000004093665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004321204,"about_ca_system_score_gemma":0.00006601093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001399198,"about_ca_topic_score_gemma":0.0004694107,"domain_scores_codex":[0.9991778,0.0001227652,0.0001229978,0.0003018829,0.0001122125,0.0001623416],"domain_scores_gemma":[0.9996105,0.00003001461,0.00003992507,0.0001746768,0.00005934581,0.0000855174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002614933,0.00002099243,0.003733055,0.000006223073,0.00001064824,0.00000495662,0.00007034093,2.92083e-7,0.9362544,0.0001541806,0.05315011,0.00397991],"study_design_scores_gemma":[0.001760917,0.00009564424,0.1021135,0.0001773893,0.000003352951,0.000007656637,0.00004347708,4.091147e-7,0.7637443,0.0004245154,0.1313813,0.0002475456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981438,0.001174191,0.00005468983,0.01645111,0.0001728795,0.0002530364,0.0001909504,0.000009415957,0.0002557312],"genre_scores_gemma":[0.9944171,0.0001080801,0.0004028439,0.001493588,0.0001586621,0.00004357413,0.000005860951,0.00001322753,0.00335711],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1725101,"threshold_uncertainty_score":0.4005019,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3102624934","doi":"10.1038/s41467-020-19532-z","title":"The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice","year":2020,"lang":"en","type":"article","venue":"Nature Communications","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":574,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Institute of Genetics; Japan Science and Technology Agency; Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; University of Dundee; Asahi Glass Foundation; Takeda Science Foundation","keywords":"Degron; Gene knockdown; Mutant; Cell biology; Yeast; Degradation (telecommunications); Saccharomyces cerevisiae; Function (biology); Phenotype; Protein degradation; Auxin; Chemistry; Biology; Gene; Biochemistry; Computer science; Ubiquitin ligase; Ubiquitin","retraction":null,"screen_n_in":null,"score":{"opus":0.01217306286600655,"gpt":0.2527165831789991,"spread":0.2405435203129925,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001535651,0.00009572856,0.00008078714,0.00004459749,0.0002198289,0.00004157119,0.0005827824,0.0002821681,0.000002416145],"category_scores_gemma":[0.0002756937,0.00007887955,0.00002654944,0.0002344979,0.0001479328,0.000009147656,0.0002142455,0.0004502227,0.000006456354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001383965,"about_ca_system_score_gemma":0.00006296215,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001842039,"about_ca_topic_score_gemma":0.0009923527,"domain_scores_codex":[0.9993184,0.0001045118,0.0001707505,0.0002037542,0.00006817172,0.0001344699],"domain_scores_gemma":[0.9991103,0.00003141454,0.00007803862,0.0006535301,0.00007611933,0.00005052766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000673711,0.00007553794,0.00394498,0.00001359032,0.00003010944,8.377019e-7,0.00009292189,0.000008055007,0.9523466,0.01382426,0.01566611,0.01392959],"study_design_scores_gemma":[0.0008009118,0.00011878,0.001852278,0.00001435759,0.00001542732,0.000006839125,0.0002989587,0.001211801,0.231759,0.0002829119,0.7634551,0.000183619],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6572295,0.06796935,0.001404741,0.2673174,0.0003058958,0.002211541,0.0001483389,0.0001418866,0.003271282],"genre_scores_gemma":[0.9958377,0.0008212474,0.001611876,0.001329595,0.0000417362,0.00007933023,0.000111426,0.00001185606,0.0001551734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.747789,"threshold_uncertainty_score":0.3216615,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2237475663","doi":"10.1016/j.cell.2015.11.062","title":"Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance","year":2016,"lang":"en","type":"article","venue":"Cell","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":497,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Human Genome Research Institute","keywords":"Biology; Breast cancer; Computational biology; Cancer; Small hairpin RNA; Point mutation; Gene; Genetics; Genomics; Genome-wide association study; Genome; Bioinformatics; Mutation; Single-nucleotide polymorphism; RNA; Genotype","retraction":null,"screen_n_in":null,"score":{"opus":0.006695832529943527,"gpt":0.2053287445523454,"spread":0.1986329120224019,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000412734,0.00005034074,0.00005057648,0.00001381999,0.0000366042,0.000003475078,0.00003989941,0.00004283178,0.0002541625],"category_scores_gemma":[0.000004125577,0.00003700409,0.0000210968,0.00001560106,0.00006772421,0.000002456366,0.00002874544,0.0000173424,0.000002961123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007955484,"about_ca_system_score_gemma":0.00003033473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000956205,"about_ca_topic_score_gemma":0.00004004822,"domain_scores_codex":[0.9996608,0.00001526559,0.00007807392,0.0001341979,0.00004370322,0.00006795493],"domain_scores_gemma":[0.9997807,0.000004150966,0.00003925009,0.0001099723,0.00003607791,0.00002983598],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002810309,0.00001134034,0.008485206,0.00001380786,0.000005747369,1.167998e-7,0.000008307885,2.708964e-7,0.9765691,0.0001624227,0.01438941,0.0003262098],"study_design_scores_gemma":[0.0006870456,0.00004175661,0.0460075,0.00001718351,0.000005676207,0.00000160367,0.00002481376,4.392154e-7,0.9204721,0.0002093684,0.03243595,0.00009658971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950761,0.0008876168,0.000116809,0.0002424962,0.0000679231,0.00004960664,0.00008126062,0.000004006236,0.00347421],"genre_scores_gemma":[0.9867218,0.0001702136,0.00006956318,0.0000443203,0.0001311107,0.000006848583,0.0000206389,0.000005686636,0.01282979],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05609698,"threshold_uncertainty_score":0.2782901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024469844","doi":"10.1073/pnas.1310658110","title":"RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain","year":2013,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":481,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Wellcome Trust; GlaxoSmithKline; Pfizer","keywords":"Bromodomain; Selectivity; Chemistry; BET inhibitor; Biochemistry; Gene; Epigenetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02047971555116908,"gpt":0.2644422861358543,"spread":0.2439625705846852,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006918411,0.00007661757,0.00009495488,0.00004786918,0.0001544082,0.00001593377,0.0004151372,0.0000775809,0.00002069144],"category_scores_gemma":[0.0001298334,0.00004203755,0.00006502843,0.0002380943,0.0007074837,0.00005767192,0.00003358578,0.00006487576,1.476617e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008427331,"about_ca_system_score_gemma":0.00005209487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005489643,"about_ca_topic_score_gemma":8.600733e-7,"domain_scores_codex":[0.9990149,0.000007943006,0.0002026867,0.0001901031,0.0004811721,0.0001031818],"domain_scores_gemma":[0.999293,0.00003503292,0.0002615286,0.00001297137,0.000370547,0.00002694375],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003286827,0.00004037346,0.001709544,0.00002989966,0.00001783747,1.83373e-10,0.00004552679,0.00002082527,0.988025,0.00837987,0.001473071,0.0002251797],"study_design_scores_gemma":[0.0002368862,0.0002234733,0.04092262,0.00001841744,0.000006987445,0.000003058837,0.0001040167,0.0003076486,0.9495341,0.007412705,0.001171114,0.00005903411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975383,0.00008946522,0.00003206454,0.001457442,0.00001502624,0.0003888255,0.00003818054,0.000002782074,0.0004378704],"genre_scores_gemma":[0.9973158,0.000004479503,0.002067631,0.0001602208,0.0001135295,0.00004501661,0.000001091117,0.000004240328,0.0002879622],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03921307,"threshold_uncertainty_score":0.2606753,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000832682","doi":"10.1016/j.molcel.2007.06.027","title":"Systematic Analysis of the Protein Interaction Network for the Human Transcription Machinery Reveals the Identity of the 7SK Capping Enzyme","year":2007,"lang":"en","type":"article","venue":"Molecular Cell","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":441,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Université Laval; University of Toronto; Université de Sherbrooke; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Biology; Transcription (linguistics); Transcription factor; Computational biology; Interaction network; Cell biology; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.009670997196912508,"gpt":0.2525091586157963,"spread":0.2428381614188838,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001273752,0.000111127,0.0001802292,0.00003426186,0.0002259199,0.00002345708,0.0004419182,0.00008057695,0.000005564339],"category_scores_gemma":[0.0001167197,0.0000521474,0.0004927551,0.000409004,0.00008448788,0.000006795938,0.00006742844,0.0001090908,3.239646e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001764765,"about_ca_system_score_gemma":0.00001779802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008422919,"about_ca_topic_score_gemma":0.0002448325,"domain_scores_codex":[0.9987375,0.0002898836,0.0004433536,0.0001599787,0.0002243213,0.0001449671],"domain_scores_gemma":[0.9987695,0.00003757021,0.0004317451,0.0006415719,0.0001032503,0.00001641815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00001475154,0.00002545754,0.0002296786,0.0003750262,0.0002571601,9.779247e-8,0.00008494472,0.001692017,0.9966058,0.0004934532,0.000182987,0.00003868586],"study_design_scores_gemma":[0.0001650468,0.00003392599,0.002085714,0.0002270928,0.0006600562,8.626326e-7,0.0001709727,0.000786097,0.9951729,0.0001676512,0.0004550564,0.00007460625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9002138,0.001276818,0.09600662,0.0002364016,0.000233787,0.001715054,0.00001085899,0.000004252894,0.0003023717],"genre_scores_gemma":[0.9990934,0.000007892244,0.00008196463,0.0002048003,0.00007269459,0.00007572826,0.00001976545,0.0000115728,0.0004321932],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09887955,"threshold_uncertainty_score":0.2126509,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2027275928","doi":"10.1038/nchembio.1197","title":"Target validation using chemical probes","year":2013,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":435,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"University of Toronto; University of Oxford; Harvard University; Pfizer","keywords":"Relevance (law); Chemical biology; Computer science; Computational biology; Interpretation (philosophy); Biochemical engineering; Data science; Biology; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.007007253976963497,"gpt":0.2589165346044496,"spread":0.2519092806274861,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007479441,0.0001616582,0.0001462173,0.00003210815,0.00003448941,0.00001952013,0.0002100858,0.0009381233,0.0002032878],"category_scores_gemma":[0.0003076296,0.0001356665,0.00008320793,0.00009409789,0.000125549,0.000007092156,0.0001269327,0.0003232957,0.00004895019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002257479,"about_ca_system_score_gemma":0.00003990997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008863246,"about_ca_topic_score_gemma":1.363817e-7,"domain_scores_codex":[0.9990339,0.00004162549,0.0001996296,0.0003887475,0.00007423752,0.0002618683],"domain_scores_gemma":[0.9994584,0.00001209457,0.00007213679,0.0002340552,0.000128639,0.00009469324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00001463764,0.00003440071,0.0007937881,0.000006413134,0.00001610618,1.829768e-7,0.000003343688,7.858182e-7,0.9932189,0.0003286164,0.004662577,0.0009202653],"study_design_scores_gemma":[0.0002508799,0.00003655862,0.0000380602,0.00000509148,0.000005238774,0.0000122746,0.000005154442,0.00008388827,0.9722037,0.001355182,0.02582891,0.0001750613],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996436,0.0006362261,0.0008350787,0.0005173039,0.0002203506,0.0002653864,0.00001122731,0.00003200947,0.00104644],"genre_scores_gemma":[0.9887002,0.00001431384,0.008914944,0.0008343648,0.0006247146,0.00003799832,0.0007483866,0.00001711633,0.0001080211],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02116634,"threshold_uncertainty_score":0.7235667,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2299417213","doi":"10.1158/1535-7163.mct-15-0843","title":"An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies","year":2016,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":432,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University College of the North","funders":"","keywords":"Cancer; In vivo; Combination therapy; Cancer cell; Pharmacology; Medicine; Computational biology; Cancer therapy; Drug; Cancer research; Cancer treatment; Biology; Internal medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.03619010624958395,"gpt":0.3574481275927425,"spread":0.3212580213431586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001556712,0.0001726893,0.0001392601,0.00006675508,0.00007781714,0.00006529698,0.0002848188,0.0001698555,0.00004162183],"category_scores_gemma":[0.00001111444,0.000140876,0.00006543916,0.0001227193,0.00008681051,0.00001650374,0.00005376325,0.00006090048,0.00001710071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008091458,"about_ca_system_score_gemma":0.0002150372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006616182,"about_ca_topic_score_gemma":0.0001306849,"domain_scores_codex":[0.9988919,0.00009797918,0.000208081,0.00036074,0.0001938397,0.0002474025],"domain_scores_gemma":[0.9991863,0.000008816042,0.00008853555,0.0004147899,0.0001814747,0.0001200979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009390715,0.0001374547,0.0002018017,0.000003579157,0.00007125629,0.000003223186,0.00004002374,0.00006266639,0.9744848,0.001530322,0.0002278475,0.02314314],"study_design_scores_gemma":[0.001262494,0.0006588066,0.001752551,0.00002024566,0.0000272952,0.00000521488,0.00008044876,0.00005197941,0.8664481,0.0003502244,0.1290907,0.0002519582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7615134,0.0003977157,0.23421,0.002436335,0.000271722,0.0003532871,0.00006239147,0.00003626699,0.000718889],"genre_scores_gemma":[0.9941135,0.0001085029,0.001369945,0.003888737,0.0001347971,0.00006854275,0.00008963313,0.0000365254,0.0001898132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2328401,"threshold_uncertainty_score":0.5744758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2299219969","doi":"10.1016/s2352-3026(15)00247-1","title":"Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study","year":2016,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":431,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Agence Nationale de la Recherche","keywords":"Medicine; Bromodomain; Internal medicine; Leukemia; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.01162699876201042,"gpt":0.2695873245110347,"spread":0.2579603257490243,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002456848,0.0001568674,0.0003333504,0.00004994115,0.00006596548,0.00001249151,0.0002525552,0.0001156677,0.00003070938],"category_scores_gemma":[0.00007934574,0.00008108587,0.00003148707,0.0001248027,0.0001333594,0.000009972955,0.0001017806,0.00009596818,0.000031057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002193767,"about_ca_system_score_gemma":0.00005207538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009447534,"about_ca_topic_score_gemma":0.00009216399,"domain_scores_codex":[0.9987852,0.0002160844,0.0002532556,0.0003144998,0.0001416317,0.0002893383],"domain_scores_gemma":[0.9992388,0.00002610705,0.0001188141,0.0004981834,0.00007012468,0.0000479029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005667623,0.002588207,0.9006513,0.00002809894,0.0003102167,0.0001170799,0.0005000814,0.000006100984,0.05634475,0.001398303,0.02536182,0.007026392],"study_design_scores_gemma":[0.1440984,0.0128309,0.5567939,0.0002424385,0.0002648978,0.0003294602,0.0005095109,0.00003735491,0.2476587,0.002192678,0.0331752,0.001866585],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996678,0.00004020106,0.000601014,0.001614909,0.0001151777,0.0006508455,0.00002362712,0.00002179486,0.0002544163],"genre_scores_gemma":[0.9989757,0.00001135737,0.0001519128,0.0003320937,0.0001707155,0.00009159675,0.00004499507,0.0000190298,0.0002025814],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3438574,"threshold_uncertainty_score":0.3306586,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974631163","doi":"10.1016/j.febslet.2012.04.045","title":"The bromodomain interaction module","year":2012,"lang":"en","type":"review","venue":"FEBS Letters","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":377,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Genome Canada; Wellcome Trust; Novartis Foundation","keywords":"Bromodomain; Acetylation; Histone; Lysine; Computational biology; Proteome; Chemistry; Epigenetics; Translation (biology); Biochemistry; Biology; Cell biology; Gene; Amino acid; Messenger RNA","retraction":null,"screen_n_in":null,"score":{"opus":0.03125933788246484,"gpt":0.2989202822770627,"spread":0.2676609443945979,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001930147,0.0002093099,0.0002424115,0.00003264843,0.0001331963,0.00005472424,0.0002539246,0.0001744002,0.00001850347],"category_scores_gemma":[0.00003783371,0.000137244,0.0002777746,0.00006039125,0.00004475802,0.000004159217,0.0000939932,0.0001915455,0.0001573954],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003669935,"about_ca_system_score_gemma":0.00003116624,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004761352,"about_ca_topic_score_gemma":0.000004703723,"domain_scores_codex":[0.9990361,0.0001594734,0.0002430216,0.0002284119,0.0001039341,0.0002290449],"domain_scores_gemma":[0.9993028,0.0000211132,0.0001845017,0.0004225259,0.00001441453,0.00005463709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000047121,0.00001190963,0.000001055169,0.0003238585,0.00008311994,7.972007e-7,0.000003743875,3.655499e-7,0.001057864,0.00004154563,0.05648385,0.9419872],"study_design_scores_gemma":[0.00004889331,0.00001612775,0.000001098645,0.0002512484,0.00007316926,0.00002296896,0.000002339198,4.8713e-7,0.0005344177,0.000002882355,0.9988785,0.0001678804],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000670822,0.997247,0.0004653447,0.0003800224,0.001044624,0.0003220378,0.00001121171,0.00001329247,0.000449396],"genre_scores_gemma":[0.000109635,0.9961626,0.00006676115,0.0005902037,0.001492324,0.0001067281,0.000358684,0.00003850435,0.001074583],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9423946,"threshold_uncertainty_score":0.5596647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2512442926","doi":"10.1038/nchembio.2166","title":"Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors","year":2016,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":372,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Cancer Institute; Medical Research Council; Ministero dello Sviluppo Economico; Ontario Genomics Institute; Hope Funds for Cancer Research; Diamond Light Source; National Human Genome Research Institute; Wellcome Trust; National Institutes of Health; Ontario Genomics; Genome Canada; Ontario Ministry of Economic Development and Innovation; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology; Deutsche Forschungsgemeinschaft; Dana-Farber/Harvard Cancer Center; GlaxoSmithKline; Pfizer; Eli Lilly and Company","keywords":"Kinase; Enhancer; Cell biology; Biology; Transcription factor; Cyclin-dependent kinase; Processivity; Gene expression; Transcription (linguistics); Gene; Chemistry; Molecular biology; Genetics; Polymerase; Cell cycle","retraction":null,"screen_n_in":null,"score":{"opus":0.005339544952155734,"gpt":0.2519261609122563,"spread":0.2465866159601005,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002101429,0.0001552927,0.0001974442,0.00005201278,0.00002785932,0.00000404931,0.0001584246,0.000604783,0.00001393343],"category_scores_gemma":[0.002067145,0.0001031549,0.0000422172,0.00015255,0.0001494218,0.000003211905,0.0002320498,0.0001470461,0.000006542526],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001665907,"about_ca_system_score_gemma":0.00004938082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006081323,"about_ca_topic_score_gemma":0.000003899197,"domain_scores_codex":[0.9989427,0.00005143805,0.0002923461,0.0004015068,0.00007997073,0.0002320613],"domain_scores_gemma":[0.9992962,0.0000374606,0.0001244743,0.00020451,0.0002193318,0.0001179774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001012349,0.00001185065,0.001215325,0.00001462207,0.00001831645,6.474526e-7,0.000009882835,3.389946e-8,0.973074,0.0002351391,0.007564309,0.01775465],"study_design_scores_gemma":[0.0003719792,0.000161454,0.0001592727,0.00003894476,0.000004354922,0.000006705763,0.000007494112,4.753527e-7,0.8553805,0.0001727984,0.1435582,0.0001378164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935538,0.00211099,0.00132099,0.002247827,0.0002051668,0.0001725156,0.00003386707,0.00001790823,0.0003369488],"genre_scores_gemma":[0.9890484,0.0001727056,0.009471548,0.0006194984,0.0003615085,0.000005376759,0.00008778731,0.00001457202,0.0002186419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1359939,"threshold_uncertainty_score":0.466464,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3095840616","doi":"10.1177/2472555220965528","title":"E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones","year":2020,"lang":"en","type":"review","venue":"SLAS DISCOVERY","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":369,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"FP7 Ideas: European Research Council; European Commission; European Federation of Pharmaceutical Industries and Associations; Innovative Medicines Initiative; McGill University","keywords":"Ubiquitin ligase; DNA ligase; Ubiquitin; Drug discovery; Computational biology; Cereblon; Protein degradation; Ubiquitin-Protein Ligases; Proteasome; Chemistry; Biology; Biochemistry; DNA","retraction":null,"screen_n_in":null,"score":{"opus":0.03057431257181093,"gpt":0.2985406958382705,"spread":0.2679663832664596,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001192956,0.0005604189,0.0009116426,0.00007945159,0.0001074284,0.0006108864,0.0003373553,0.0003854388,0.000003983777],"category_scores_gemma":[0.0003386427,0.000429788,0.0005010855,0.0001114429,0.00005430782,0.0000420221,0.0003286218,0.0001835345,0.00001221998],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003577915,"about_ca_system_score_gemma":0.0006088553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001076469,"about_ca_topic_score_gemma":0.00005425946,"domain_scores_codex":[0.9982809,0.00004015911,0.0002608595,0.0008683422,0.0001913958,0.0003583799],"domain_scores_gemma":[0.9988738,0.00003440766,0.0002428551,0.0005197809,0.00004383442,0.000285288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002066234,0.0001058662,0.00001906571,0.009477586,0.0007373763,0.00001606481,0.0001044339,7.962038e-7,0.004356801,0.001558384,0.2499038,0.7335132],"study_design_scores_gemma":[0.0003951703,0.0004814374,0.000001959119,0.00151869,0.0002324832,0.00001732061,0.00003909177,0.000001013016,0.006997085,0.0001780824,0.9895738,0.0005638593],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005484251,0.9903232,0.001893945,0.002779545,0.00045876,0.003199559,0.0005726583,0.0000270218,0.0001968119],"genre_scores_gemma":[0.0009183321,0.9724413,0.0003945116,0.0004153042,0.002267309,0.0006355179,0.001044988,0.0001257066,0.02175699],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.73967,"threshold_uncertainty_score":0.9998154,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3138474425","doi":"10.1038/s41416-021-01321-0","title":"Achieving clinical success with BET inhibitors as anti-cancer agents","year":2021,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":354,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Government of Canada","keywords":"Medicine; Cancer; Oncology; Bioinformatics; Internal medicine; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.04076842658982904,"gpt":0.4049207177462221,"spread":0.364152291156393,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005157742,0.000314024,0.001359284,0.0000803507,0.00009809661,0.0001795076,0.0004236014,0.0004485886,0.0003351418],"category_scores_gemma":[0.0001871447,0.000284654,0.0007865796,0.0002130809,0.0001269983,0.00001889829,0.0001373311,0.000730964,0.00000407052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006762819,"about_ca_system_score_gemma":0.001658113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000101075,"about_ca_topic_score_gemma":0.0001437603,"domain_scores_codex":[0.9973251,0.0003303342,0.001212726,0.0004176558,0.0004329883,0.0002811926],"domain_scores_gemma":[0.9976456,0.00002048815,0.001418516,0.0002319295,0.0004548126,0.000228609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001759401,0.00007243109,0.001133214,0.0008906561,0.0006854127,0.0002402478,0.000002749938,0.000005991652,0.0000257841,0.000001317591,0.01937806,0.9775465],"study_design_scores_gemma":[0.0005726383,0.0001749362,0.0001840513,0.02425628,0.0004774469,0.001009446,0.000008386013,1.552542e-7,0.000561782,4.372411e-7,0.9724075,0.0003469908],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01702309,0.980962,0.000027551,0.00006055571,0.001372835,0.000246333,0.00009683806,0.00000470268,0.0002060729],"genre_scores_gemma":[0.0006717519,0.993932,0.0001161686,0.0002808993,0.003796455,0.00003777686,0.00009042015,0.00007512017,0.0009994267],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9771996,"threshold_uncertainty_score":0.9999605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3173153622","doi":"10.1038/s41568-021-00367-9","title":"MYC protein interactors in gene transcription and cancer","year":2021,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":352,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Structural Genomics Consortium; Sunnybrook Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Interactome; Transcription factor; Biology; Carcinogenesis; Epigenetics; Promoter; Computational biology; Gene; Cell biology; Transcription (linguistics); Cancer research; Genetics; Gene expression","retraction":null,"screen_n_in":null,"score":{"opus":0.02906492708313017,"gpt":0.3708726183859068,"spread":0.3418076913027766,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002807606,0.0004611978,0.001313164,0.0001123423,0.00003672585,0.00004159357,0.0002070649,0.001051671,0.0001754735],"category_scores_gemma":[0.0001327241,0.0003570373,0.0004124728,0.0003325215,0.00004259809,0.00000950126,0.00007264087,0.0009170081,0.000005265043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001377009,"about_ca_system_score_gemma":0.0003839559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006057606,"about_ca_topic_score_gemma":0.0002692439,"domain_scores_codex":[0.9978942,0.0003277209,0.0006559472,0.0007146327,0.0001508287,0.0002566735],"domain_scores_gemma":[0.9991062,0.000007653933,0.0003392428,0.0003768261,0.00007728995,0.0000927556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004887422,0.00002161626,0.000005101251,0.007291025,0.00006121075,0.000003456651,0.00001426373,1.148606e-7,0.00296179,0.00001689588,0.003605936,0.9860137],"study_design_scores_gemma":[0.0001623098,0.00002512469,0.00000218291,0.02391241,0.0001495793,0.00001075067,0.000003013891,3.549411e-7,0.003666301,0.000001997633,0.9716921,0.0003738128],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001627103,0.9970787,0.00001291178,0.00009454852,0.0006308437,0.001803214,0.0001169407,0.000008265958,0.0000918595],"genre_scores_gemma":[0.00004932121,0.9952708,0.0001700549,0.0003265084,0.0007659646,0.001588933,0.0005684852,0.00005708095,0.001202814],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9856399,"threshold_uncertainty_score":0.9998882,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016988770","doi":"10.1073/pnas.1216363109","title":"Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins","year":2012,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":348,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Bromodomain; BET inhibitor; BRD4; Epigenetics; Transcription factor; Biology; Cancer research; Gene knockdown; Gene; Ectopic expression; Cell biology; Molecular biology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.02537418135966299,"gpt":0.2853383197730813,"spread":0.2599641384134184,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001257671,0.00008242166,0.0001328851,0.0001153918,0.00008682386,0.000004875831,0.0001943408,0.00009202326,0.000005354337],"category_scores_gemma":[0.0003467217,0.00006358762,0.00007333941,0.0003515295,0.0003175466,0.00003041155,0.0001259479,0.00006322283,2.464603e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009986025,"about_ca_system_score_gemma":0.00002818148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001179198,"about_ca_topic_score_gemma":1.519636e-7,"domain_scores_codex":[0.9988282,0.00001865255,0.0003396595,0.0001600817,0.0005223763,0.0001309995],"domain_scores_gemma":[0.999104,0.00001893927,0.0004599796,0.00001292621,0.000362003,0.00004221737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00001182813,0.00006281231,0.02084808,0.00009452605,0.000006764338,1.136877e-9,0.0001038384,0.00005082377,0.9778558,0.0007701744,0.0001556771,0.00003965783],"study_design_scores_gemma":[0.0001075386,0.0001072618,0.04800189,0.00006834306,0.000008936518,0.000001048807,0.00008295148,0.00006654256,0.9510099,0.0004570465,0.00002349826,0.0000650576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986365,0.0003288944,0.00002660243,0.0002816507,0.00001432553,0.0002888509,0.00002359945,0.000002665175,0.0003969153],"genre_scores_gemma":[0.9978736,0.000006247237,0.001863923,0.00006755962,0.0001264622,0.000009501502,0.000001702787,0.00000434089,0.00004667719],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02715381,"threshold_uncertainty_score":0.2593028,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220990424","doi":"10.1038/s41573-022-00409-3","title":"The emerging role of mass spectrometry-based proteomics in drug discovery","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":347,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Guelph","funders":"","keywords":"Drug discovery; Proteomics; Mass spectrometry; Computational biology; Drug; Chemistry; Data science; Pharmacology; Computer science; Medicine; Chromatography; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.01024856041706307,"gpt":0.2894495030299467,"spread":0.2792009426128836,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001755013,0.0006677636,0.001677895,0.0002608816,0.0001785578,0.000152455,0.001159189,0.0004607738,0.00003148305],"category_scores_gemma":[0.0006688398,0.0004408937,0.00137346,0.0009131334,0.0001225516,0.00003791776,0.0003597791,0.001692471,0.000007748691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001964161,"about_ca_system_score_gemma":0.0007244073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002220491,"about_ca_topic_score_gemma":0.00006775508,"domain_scores_codex":[0.9958124,0.0009954275,0.001397907,0.0008357472,0.0004810057,0.0004774714],"domain_scores_gemma":[0.9972025,0.0001376844,0.001271643,0.00128381,0.00003510865,0.00006927428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001729403,0.0005037683,0.00008107193,0.02913325,0.0004788389,0.000019581,0.00006396003,0.00003211914,0.008139903,0.002706093,0.0233397,0.9353288],"study_design_scores_gemma":[0.00020265,0.00003173699,0.000001196607,0.003328497,0.000149099,0.000005210346,0.00004956641,0.000003078082,0.003719104,0.00007666483,0.991958,0.0004751835],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009575063,0.9951335,0.0001836497,0.00009055115,0.0005878865,0.002765653,0.0001934522,0.0000101491,0.0009393828],"genre_scores_gemma":[0.0001175913,0.9943085,0.0008150421,0.0001298867,0.0004219702,0.0008280707,0.001126555,0.00009532504,0.002157073],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9686183,"threshold_uncertainty_score":0.9998043,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386446579","doi":"10.1038/s41392-023-01589-z","title":"Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials","year":2023,"lang":"en","type":"review","venue":"Signal Transduction and Targeted Therapy","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":344,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"Chengdu University; Jiangxi University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine; National Natural Science Foundation of China","keywords":"Drug discovery; Computational biology; Drug development; Biology; Drug; Bioinformatics; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.1058780823456495,"gpt":0.4042721095420451,"spread":0.2983940271963956,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003462764,0.0004035546,0.001169192,0.00012845,0.0001422626,0.0001069969,0.0002697709,0.0003338964,0.0001300716],"category_scores_gemma":[0.0003795857,0.0002532422,0.0004913758,0.0004277682,0.000099648,0.00002735953,0.00003575553,0.0004697359,0.00002015305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002274095,"about_ca_system_score_gemma":0.0001967732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002792546,"about_ca_topic_score_gemma":0.00005115883,"domain_scores_codex":[0.9949706,0.002329527,0.001430953,0.0007601105,0.0002219983,0.0002868465],"domain_scores_gemma":[0.9988737,0.0002463426,0.0004089482,0.0002988608,0.00005662762,0.0001155595],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002006468,0.0000707702,0.000007046134,0.0002132594,0.0001695532,0.000001598282,0.00006577692,0.000009281376,0.001106953,0.00001792252,0.00108181,0.9970554],"study_design_scores_gemma":[0.000630416,0.0001506779,0.000004887767,0.0008850107,0.00005232401,0.000001571676,0.0001198146,0.00000270283,0.002741704,0.0001979872,0.9948865,0.0003263964],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006150981,0.9942813,0.0007180621,0.0005121008,0.001081301,0.002552894,0.0001726607,0.00003610934,0.00003049336],"genre_scores_gemma":[0.0001142518,0.9957568,0.0001794005,0.0002418838,0.00178765,0.00057369,0.0008670054,0.00006570142,0.0004136088],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.996729,"threshold_uncertainty_score":0.999992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2747084483","doi":"10.1038/nm.4379","title":"Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation","year":2017,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":301,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Bromodomain; BRD4; BET inhibitor; Cancer research; Ubiquitin ligase; Prostate cancer; Biology; mTORC1; Signal transducing adaptor protein; Protein kinase B; Chemistry; Cell biology; Cancer; Ubiquitin; Epigenetics; Biochemistry; Genetics; Gene; Signal transduction","retraction":null,"screen_n_in":null,"score":{"opus":0.005170535343120824,"gpt":0.2670491265184531,"spread":0.2618785911753323,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002835868,0.0001895087,0.0002036254,0.00008484823,0.0001492451,0.00003281806,0.0001567455,0.0003871365,0.00003245399],"category_scores_gemma":[0.001061346,0.0001565055,0.00001802415,0.0001427631,0.0001965181,0.00002988144,0.00006427639,0.0003396451,0.000001193141],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005594566,"about_ca_system_score_gemma":0.00008368133,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001526442,"about_ca_topic_score_gemma":0.0004975154,"domain_scores_codex":[0.9987615,0.00006076078,0.000282772,0.000423466,0.0002668375,0.0002046647],"domain_scores_gemma":[0.9990529,0.0000116498,0.0002751752,0.0003620452,0.000207672,0.00009056048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003475424,0.00003306257,0.007806019,0.00007231132,0.00001810335,0.000002199741,0.0002464895,2.944737e-7,0.9681166,0.00005623748,0.02059806,0.00270309],"study_design_scores_gemma":[0.002495784,0.0001808133,0.01217387,0.0003533814,0.00001034428,6.735453e-7,0.00005645657,0.00001563894,0.9015236,0.0001674496,0.08281376,0.0002081977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9850681,0.003948193,0.0000407957,0.009554834,0.0001870569,0.0008174792,0.00007617052,0.00001895355,0.0002883936],"genre_scores_gemma":[0.9962518,0.0004833466,0.00008366686,0.0007844226,0.0003722484,0.0001048785,0.0007515422,0.00002431616,0.001143763],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06659296,"threshold_uncertainty_score":0.6382107,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3008322752","doi":"10.1126/sciadv.aay5064","title":"PHOTACs enable optical control of protein degradation","year":2020,"lang":"en","type":"article","venue":"Science Advances","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":298,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institutes of Health; National Cancer Institute; New York University; York University; Howard Hughes Medical Institute","keywords":"Degradation (telecommunications); Protein degradation; Modular design; Computer science; Control (management); Biophysics; Chemistry; Cell biology; Biology; Biochemistry; Telecommunications; Artificial intelligence","retraction":null,"screen_n_in":null,"score":{"opus":0.009361328203190755,"gpt":0.2499912143661777,"spread":0.240629886162987,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001567574,0.000058036,0.0000710314,0.00002082334,0.00006678142,0.000016281,0.0002058416,0.00002605423,0.00001477955],"category_scores_gemma":[0.0003922136,0.00004893941,0.00002550614,0.0002323284,0.0003268958,0.00002846736,0.00003689507,0.00003317827,0.000007047103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000512644,"about_ca_system_score_gemma":0.0001147502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001679144,"about_ca_topic_score_gemma":0.000001306218,"domain_scores_codex":[0.9992954,0.00001272288,0.0001267184,0.0002245525,0.0002029181,0.000137726],"domain_scores_gemma":[0.9996337,0.000003549558,0.00006538148,0.0001147772,0.00009983351,0.0000827548],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002867451,0.00001168314,0.0002174779,0.000007838165,0.000001450949,1.909039e-7,0.00001060245,0.00005270996,0.9915205,0.0005451886,0.00003671787,0.007566937],"study_design_scores_gemma":[0.0002368987,0.0002227099,0.00006811011,0.00000594871,0.000001769911,6.520829e-7,0.00005191006,0.0001684399,0.9756875,0.00009878021,0.02339488,0.00006239407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9597808,0.001408497,0.03327598,0.001440713,0.0001101114,0.0003925482,0.000009389528,0.00001824658,0.003563746],"genre_scores_gemma":[0.9958416,0.00001495417,0.003591558,0.0003124438,0.00007587469,0.00001395023,0.000005519476,0.000003372208,0.0001407914],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03606077,"threshold_uncertainty_score":0.1995691,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135676046","doi":"10.1158/1078-0432.ccr-12-3066","title":"Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma","year":2013,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":295,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Bromodomain; Glioblastoma; Biology; Cancer research; Computational biology; Medicine; Genetics; Epigenetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.0788149943909722,"gpt":0.4284188748675226,"spread":0.3496038804765503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001079879,0.00009378984,0.0001705222,0.00006879865,0.00008079087,0.00002386163,0.0002070798,0.0002184991,0.0009006646],"category_scores_gemma":[0.0007187302,0.00008372262,0.0001243706,0.0001808215,0.0005285245,0.000007688373,0.0002892929,0.0002730378,0.0001472499],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002115433,"about_ca_system_score_gemma":0.0001808333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001750895,"about_ca_topic_score_gemma":0.00007184847,"domain_scores_codex":[0.9980744,0.0004042878,0.0004295058,0.0003677078,0.0004046524,0.0003194075],"domain_scores_gemma":[0.9987602,0.00007812826,0.00007558849,0.000351354,0.0005333495,0.0002014233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003601945,0.0002959436,0.008403907,0.00004452181,0.00005546764,0.000003957757,0.00002637157,0.000008923089,0.8608479,0.0002488425,0.0923467,0.03735723],"study_design_scores_gemma":[0.001341822,0.001841125,0.01818425,0.00005167105,0.000007579826,0.000001631334,0.00009114177,0.00009964332,0.9407355,0.001237145,0.03621225,0.0001962564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963389,0.0005720049,0.0002995604,0.0007483477,0.0001562879,0.0004343205,0.00002637897,0.000008745981,0.001415456],"genre_scores_gemma":[0.9970765,0.0005924465,0.0005472328,0.0002253694,0.0005121731,0.0001288587,0.00003303063,0.00001679117,0.0008676428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07988753,"threshold_uncertainty_score":0.9861646,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995827055","doi":"10.1021/ja412434f","title":"Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains","year":2014,"lang":"en","type":"article","venue":"Journal of the American Chemical Society","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":285,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Biotechnology and Biological Sciences Research Council; Canadian Institutes of Health Research; European Commission; British Heart Foundation; Wellcome Trust; Wellcome","keywords":"Bromodomain; Chemistry; BRD4; Small molecule; Selectivity; Lead compound; Binding site; Combinatorial chemistry; Stereochemistry; Biochemistry; In vitro; DNA","retraction":null,"screen_n_in":null,"score":{"opus":0.006335565921639335,"gpt":0.2271048963405571,"spread":0.2207693304189177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002183551,0.00006603227,0.0001275279,0.000004592865,0.00005626732,0.00001706614,0.0001972126,0.00003784547,7.289685e-7],"category_scores_gemma":[0.0002087236,0.00003603969,0.0002506258,0.00006963047,0.0002678866,0.000004907055,0.00007611446,0.00007901624,3.03408e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001019762,"about_ca_system_score_gemma":0.00003273847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000426977,"about_ca_topic_score_gemma":3.393066e-7,"domain_scores_codex":[0.9995384,0.00001776362,0.0001868036,0.00007730482,0.0000964283,0.00008329534],"domain_scores_gemma":[0.9993051,0.00005334969,0.0003902857,0.0001402193,0.00008164442,0.00002944782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00005102902,0.00002375735,0.0002163239,0.000008684497,0.00005880708,1.407077e-8,0.00003191393,0.0003838383,0.9960355,0.00002391679,0.002527027,0.0006392064],"study_design_scores_gemma":[0.0003552295,0.0001613424,0.0002411119,0.00001425452,0.00003944313,0.000008596534,0.00009920062,0.002523164,0.9952544,0.00004586326,0.001202982,0.00005439829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9105573,0.0001799028,0.08746555,0.001636645,0.00005309359,0.00007970422,0.000004824169,0.000001190892,0.00002179181],"genre_scores_gemma":[0.9927596,0.0002357332,0.005893283,0.0007836701,0.0002459058,0.000003017886,0.000003054717,0.00000885294,0.00006682996],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08220236,"threshold_uncertainty_score":0.1469656,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2028561673","doi":"10.1021/jm300346w","title":"Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites","year":2012,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":273,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canada Foundation for Innovation; Wellcome Trust; Cancer Research UK; Takeda Pharmaceuticals North America; Abbott Laboratories; Wellcome; GlaxoSmithKline; Canadian Institutes of Health Research; National Institute for Health and Care Research; Novartis; Pfizer","keywords":"Bromodomain; Druggability; Chemistry; Computational biology; Lysine; Drug discovery; Epigenetics; Amino acid; Biochemistry; Gene; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.01226193625074663,"gpt":0.2757646594124243,"spread":0.2635027231616777,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000589379,0.00009149162,0.0002201134,0.00005540322,0.00003362217,0.000006310897,0.000101867,0.0001028003,0.00007000066],"category_scores_gemma":[0.0003369737,0.0000718504,0.0001202711,0.000177017,0.0001239203,0.00001315838,0.00003259126,0.0001252105,2.34272e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002254515,"about_ca_system_score_gemma":0.00004128119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003123913,"about_ca_topic_score_gemma":9.436274e-7,"domain_scores_codex":[0.9991215,0.00003963344,0.0003854547,0.00009792535,0.0002340397,0.0001214269],"domain_scores_gemma":[0.9990947,0.00002197467,0.0004493122,0.0001480845,0.0001494495,0.0001365002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006220661,0.00002414673,0.1078957,0.00004388366,0.0001617417,4.250982e-7,0.00004904257,0.000002889876,0.8907515,0.00000265209,0.0001883033,0.0008175101],"study_design_scores_gemma":[0.0004062002,0.00008243906,0.06810864,0.00002005441,0.00025841,0.00006925523,0.0003095638,0.00007695494,0.9301506,0.0000162077,0.0004262444,0.00007538125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976739,0.001266848,0.0006125803,0.0001928748,0.00005204822,0.00002986635,0.000006948621,0.000001652738,0.000163301],"genre_scores_gemma":[0.9985379,0.00007487053,0.0007801158,0.00001829676,0.0004550563,6.679358e-7,0.00004308349,0.000005010461,0.00008500726],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03978705,"threshold_uncertainty_score":0.2929974,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2616008841","doi":"10.1126/scitranslmed.aah5084","title":"BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure","year":2017,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":269,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BIO (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Bromodomain; Transactivation; BRD4; Pressure overload; Heart failure; Induced pluripotent stem cell; Coactivator; Cancer research; Epigenetics; Biology; Medicine; Bioinformatics; Transcription factor; Internal medicine; Gene; Genetics; Cardiac hypertrophy","retraction":null,"screen_n_in":null,"score":{"opus":0.01111003851060657,"gpt":0.2657487783509653,"spread":0.2546387398403588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006528163,0.0001078763,0.0001113721,0.0001161202,0.0003430409,0.00004697941,0.0001337375,0.00006728376,0.00003681531],"category_scores_gemma":[0.0001412839,0.00009376682,0.00002179281,0.0001029852,0.001239426,0.00006618396,0.00002389511,0.0001039638,0.000001366184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009373968,"about_ca_system_score_gemma":0.0001242853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001941635,"about_ca_topic_score_gemma":0.0001239594,"domain_scores_codex":[0.9989066,0.00003625087,0.000213122,0.0003170669,0.0003323585,0.0001946284],"domain_scores_gemma":[0.9995401,0.0000128819,0.00006535756,0.0001992155,0.00008540143,0.0000970373],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00005838223,0.00002188087,0.03234777,0.00002341528,0.000004143121,0.000002250793,0.0001088843,0.0002724855,0.9622517,0.003943349,0.000392149,0.0005736467],"study_design_scores_gemma":[0.002971217,0.0002684196,0.8804257,0.0002912793,0.00001123273,0.00005445531,0.00009369343,0.002920578,0.100647,0.003397632,0.008600104,0.0003186653],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9824352,0.0004495571,0.00251194,0.01369409,0.0001779192,0.0003149064,0.000009570877,0.00000957976,0.0003972447],"genre_scores_gemma":[0.9984254,0.00003161845,0.0009123461,0.0002220043,0.0002596162,0.00002324112,0.00007464174,0.000006701688,0.00004442662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8616046,"threshold_uncertainty_score":0.4566718,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152855058","doi":"10.1093/nar/gkn061","title":"LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated","year":2008,"lang":"en","type":"article","venue":"Nucleic Acids Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":251,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"P-TEFb; snRNP; Molecular biology; RNA polymerase II; Biology; RNA; Chemistry; Gene expression; Biochemistry; RNA splicing; Gene; Promoter","retraction":null,"screen_n_in":null,"score":{"opus":0.05123672583281211,"gpt":0.295641692870347,"spread":0.2444049670375349,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005883281,0.0001116603,0.0001688636,0.00006904554,0.0003567823,0.00002236135,0.0003261381,0.0001825185,0.0001418372],"category_scores_gemma":[0.0003261752,0.00008768075,0.0000825957,0.0003264418,0.0003853487,0.000008837525,0.0003427454,0.0002770478,0.00001954816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004250601,"about_ca_system_score_gemma":0.0001260384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001068599,"about_ca_topic_score_gemma":0.00001992077,"domain_scores_codex":[0.9983603,0.0002609623,0.0002032623,0.00030238,0.000536176,0.0003368774],"domain_scores_gemma":[0.9989943,0.00002579409,0.00009508167,0.0004523151,0.000333761,0.00009874113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007616716,0.0002067027,0.05694716,0.00004028889,0.00007785606,0.000005970872,0.0002873421,0.000002954679,0.7824628,0.00006679543,0.1594341,0.000391885],"study_design_scores_gemma":[0.001029766,0.0002704852,0.09595905,0.00007617395,0.000007925882,0.00001565423,0.0003864124,0.0001136646,0.7410513,0.00007525092,0.1608292,0.000185142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944428,0.0006386986,0.00001086316,0.001097799,0.00005846007,0.0003001367,0.00007102687,0.000009729943,0.003370484],"genre_scores_gemma":[0.9938627,0.0005299069,0.00008969841,0.0002426751,0.00006745155,0.00001411694,0.00003113203,0.00001919038,0.005143152],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04141147,"threshold_uncertainty_score":0.3575518,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965466808","doi":"10.1016/j.molcel.2005.05.012","title":"Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation","year":2005,"lang":"en","type":"article","venue":"Molecular Cell","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":242,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Biology; E2F; Transcription factor; Cell biology; Retinoblastoma protein; Chromatin; Pioneer factor; Forkhead Transcription Factors; Chromatin immunoprecipitation; Promoter; Genetics; Chromatin remodeling; Gene; Gene expression; Cell cycle","retraction":null,"screen_n_in":null,"score":{"opus":0.007227782632790802,"gpt":0.2050898648381059,"spread":0.1978620822053151,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001580548,0.0001345639,0.00009973615,0.00005143256,0.00006544331,0.00002424848,0.0002268488,0.00009041625,0.00003760844],"category_scores_gemma":[0.00005269943,0.0001050637,0.00009365864,0.000129971,0.000028514,0.000004327949,0.0001038193,0.00007244426,0.00005302849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001320213,"about_ca_system_score_gemma":0.00003247342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006853171,"about_ca_topic_score_gemma":0.000007009463,"domain_scores_codex":[0.9990728,0.00007867855,0.0002135016,0.0002560581,0.000191453,0.0001874334],"domain_scores_gemma":[0.9993805,0.0000026647,0.0001033391,0.0003834331,0.00006680784,0.00006329015],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00001459988,0.00007092454,0.00006671363,0.00001875186,0.00001265096,7.977062e-7,0.00005199407,0.00006677725,0.9960636,0.00008428648,0.0006322982,0.002916613],"study_design_scores_gemma":[0.0002339323,0.0001421346,0.00004899855,0.00001487651,0.00001050167,6.452925e-7,0.00001953845,0.0001128831,0.9526839,0.00001731725,0.04658841,0.0001268707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.973899,0.0003844646,0.02244379,0.0008371942,0.00005765195,0.0007243425,0.000008756772,0.00001285532,0.001631956],"genre_scores_gemma":[0.995604,0.000005481548,0.002021922,0.0002035323,0.0001357154,0.00006877582,0.00009096054,0.00002322798,0.001846408],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04595611,"threshold_uncertainty_score":0.4284372,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3136508589","doi":"10.1016/j.cell.2021.03.026","title":"BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection","year":2021,"lang":"en","type":"article","venue":"Cell","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":233,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Resverlogix (Canada)","funders":"National Health and Medical Research Council; Deutsche Forschungsgemeinschaft; Australian Research Council; QIMR Berghofer Medical Research Institute","keywords":"Biology; Inflammation; Bromodomain; Cytokine storm; Cardiac dysfunction; Immunology; Myocarditis; Cytokine; HMGB1; Viral Myocarditis; Virus; Internal medicine; Coronavirus disease 2019 (COVID-19); Heart failure; Gene; Medicine; Infectious disease (medical specialty); Disease; Acetylation; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.01115273077099616,"gpt":0.2303323790153184,"spread":0.2191796482443223,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008965132,0.00009030131,0.00007534507,0.00003300271,0.00008194614,0.00003747662,0.00001575908,0.0001149498,0.00001233817],"category_scores_gemma":[0.00004621132,0.00009868985,0.000041612,0.00008552341,0.00001817233,0.000009948972,0.00004254458,0.00006707859,0.00001733073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001530281,"about_ca_system_score_gemma":0.0000447466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002919905,"about_ca_topic_score_gemma":0.00003143733,"domain_scores_codex":[0.9994136,0.00005340565,0.0001319494,0.0002251844,0.00007725677,0.00009857057],"domain_scores_gemma":[0.9996471,0.000003905785,0.00005601467,0.0001581493,0.0001057682,0.00002902578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000008534224,0.00001548833,0.0007594432,0.00001443751,0.000008868004,9.690043e-7,0.00001882743,0.000002312515,0.9935002,0.00001868133,0.00269306,0.002959212],"study_design_scores_gemma":[0.000303682,0.00006741384,0.001613965,0.000007963497,0.0000122208,0.000004815138,0.00001610183,0.00001934268,0.9517527,0.0000610456,0.04603018,0.0001105226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937505,0.0002024395,0.000787971,0.0001390032,0.0003630971,0.0001172715,0.000004831608,0.00002041293,0.004614439],"genre_scores_gemma":[0.9981961,0.0001677908,0.0001116839,0.0001391605,0.000405891,0.00001938187,0.000376722,0.00001090829,0.000572352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04333712,"threshold_uncertainty_score":0.4024455,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137429553","doi":"10.1158/0008-5472.can-15-0236","title":"Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":230,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Canadian Institutes of Health Research; Rosetrees Trust; Cancer Research UK; Wellcome Trust","keywords":"Bromodomain; Cancer research; Cancer; Leukemia; Small molecule; Cancer therapy; Medicine; Chemistry; Pharmacology; Internal medicine; Biochemistry; Epigenetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1686787036596094,"gpt":0.3887608295033915,"spread":0.2200821258437821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005835435,0.00006734802,0.00009367893,0.00004564201,0.00005885575,0.00000922798,0.0002039528,0.00009445418,0.000005860394],"category_scores_gemma":[0.0002492212,0.0000491831,0.00006756457,0.000206464,0.0001444177,0.00000335455,0.0000712728,0.00009160324,5.883186e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009421686,"about_ca_system_score_gemma":0.0008891005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001850694,"about_ca_topic_score_gemma":0.0001275995,"domain_scores_codex":[0.999075,0.0001749137,0.0001560555,0.0001878499,0.0002384333,0.0001677806],"domain_scores_gemma":[0.9988894,0.00001512431,0.00007137324,0.0002502537,0.000721202,0.00005260485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000210127,0.00002720628,0.0001821489,0.00001407358,0.00002506619,5.510381e-8,0.0001147739,0.00005835821,0.9821406,0.0001426783,0.01547063,0.001614277],"study_design_scores_gemma":[0.0008904143,0.0003976555,0.0001177117,0.00001477483,0.000002347047,5.000298e-7,0.00005690472,0.0001381229,0.9900612,0.000148358,0.008117444,0.00005458632],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963455,0.001419258,0.0007684468,0.0002796951,0.0001127242,0.000664272,0.0000345633,0.000002601356,0.0003729902],"genre_scores_gemma":[0.9980805,0.0001272584,0.0002635342,0.0000601657,0.0003444057,0.0002493636,0.00002695541,0.00001492288,0.0008329087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007920574,"threshold_uncertainty_score":0.2005629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117138389","doi":"10.1128/mcb.01297-08","title":"Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes","year":2008,"lang":"en","type":"article","venue":"Molecular and Cellular Biology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Bromodomain; Histone acetyltransferase; PHD finger; Zinc finger; Acetyltransferase; Acetylation; Biology; Histone; PCAF; Enhancer; Chromatin; Genetics; Histone H3; Cell biology; Chemistry; Transcription factor; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.007204628355651102,"gpt":0.2300025420595001,"spread":0.222797913703849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001227772,0.0002670756,0.0003224503,0.00009970708,0.0001037087,0.000006260791,0.0002116408,0.0002759069,0.00003418697],"category_scores_gemma":[0.00004606754,0.0002531614,0.000181864,0.0001210303,0.0005241855,0.000003293228,0.00009029344,0.0001537766,0.000005026407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007930425,"about_ca_system_score_gemma":0.00006518339,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005349841,"about_ca_topic_score_gemma":0.000007879436,"domain_scores_codex":[0.9985459,0.0001944831,0.0003300004,0.0004918255,0.0001229956,0.0003147686],"domain_scores_gemma":[0.9992297,0.000009010174,0.00009275626,0.0004482297,0.00008150904,0.0001388355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007606022,0.00007820167,0.0005466845,0.00002679704,0.00007192029,0.00004553184,0.00006628457,0.0000428446,0.9963494,0.001643703,0.0002383842,0.0008141908],"study_design_scores_gemma":[0.0007862882,0.000548254,0.0001023516,0.000008785772,0.00002436479,0.0001130015,0.00002195259,0.00002143398,0.9789264,0.0004060305,0.01876198,0.0002792181],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9228963,0.005117009,0.07047838,0.0003248863,0.00009070364,0.0002461256,0.00004015462,0.00002024042,0.0007862212],"genre_scores_gemma":[0.9972798,0.0002010284,0.001204436,0.0006038483,0.00005814098,0.00002228109,0.0004567776,0.00003234651,0.00014133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07438353,"threshold_uncertainty_score":0.9999921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2780843582","doi":"10.1038/nature25169","title":"Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling","year":2017,"lang":"en","type":"article","venue":"Nature","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":227,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; McMaster University; SickKids Foundation; University Health Network; University of Toronto; Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Institutes of Health","keywords":"Ependymoma; Enhancer; Profiling (computer programming); Computational biology; Biology; Cancer research; Medicine; Genetics; Pathology; Gene; Computer science; Transcription factor","retraction":null,"screen_n_in":null,"score":{"opus":0.006555520905130795,"gpt":0.2965779770880875,"spread":0.2900224561829567,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001052482,0.00008954428,0.00008777288,0.00001502746,0.0001268829,0.00002640606,0.0002617265,0.0006251403,0.00004212068],"category_scores_gemma":[0.0003018029,0.0000758,0.00006549457,0.00002031315,0.00005223879,0.00000839578,0.00007327625,0.000362155,0.000008759889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008399013,"about_ca_system_score_gemma":0.0000917887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007795601,"about_ca_topic_score_gemma":0.000004124799,"domain_scores_codex":[0.9994416,0.00001467751,0.0001343393,0.0001554828,0.0001239937,0.0001299527],"domain_scores_gemma":[0.9993835,0.000005182606,0.0001780197,0.0003159149,0.00008234425,0.00003503767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00003813603,0.00001467753,0.0005775566,0.00001603927,0.00002752835,6.17558e-7,0.00001473073,4.163654e-7,0.9889259,0.0001338244,0.005889254,0.004361276],"study_design_scores_gemma":[0.0002706373,0.00007419801,0.0002771434,0.00001263484,0.000005787998,0.000002963327,0.00002474493,0.000007543646,0.9330356,0.00008155374,0.06611837,0.00008878715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851592,0.005437352,0.0001041241,0.000364256,0.0003015904,0.0001916831,0.00001452901,0.000009362639,0.008417886],"genre_scores_gemma":[0.9969714,0.0001264982,0.0004608037,0.0004244815,0.0001690838,0.00001067385,0.0001190203,0.00001113252,0.001706937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06022912,"threshold_uncertainty_score":0.4821654,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2286718346","doi":"10.1021/acs.jmedchem.5b01865","title":"Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor","year":2016,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":224,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Structural Genomics Consortium; National Cancer Institute; National Institutes of Health; Ministero dello Sviluppo Economico; Österreichische Forschungsförderungsgesellschaft; Boehringer Ingelheim Fonds; Ontario Ministry of Economic Development and Innovation; Pershing Square Sohn Cancer Research Alliance; Wellcome Trust; Genome Canada; Boehringer Ingelheim; Pfizer; Eli Lilly and Company; Canadian Institutes of Health Research; Wellcome; Pershing Square Foundation; GlaxoSmithKline; Burroughs Wellcome Fund","keywords":"Chemistry; In vivo; Structure–activity relationship; Stereochemistry; Pharmacology; In vitro; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.00775703748647166,"gpt":0.2445047407153881,"spread":0.2367477032289164,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002938236,0.000124013,0.000212883,0.00005440891,0.00001656685,0.00000373348,0.0001821714,0.000166405,0.0001096412],"category_scores_gemma":[0.0004278742,0.00008235375,0.00006668751,0.0001044933,0.0001112376,0.00001268939,0.00001736961,0.0001558454,2.147398e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006229403,"about_ca_system_score_gemma":0.0003822131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003476066,"about_ca_topic_score_gemma":0.000002352097,"domain_scores_codex":[0.9989643,0.00007406744,0.0003863556,0.0001484634,0.0002842486,0.000142551],"domain_scores_gemma":[0.9990246,0.00003698613,0.0004089531,0.0001453225,0.0002623237,0.000121812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009672414,0.00007627306,0.0003386058,0.00002249382,0.00002692352,0.00001315946,0.00002844953,0.00004492614,0.9946885,8.615953e-7,0.000847057,0.002945552],"study_design_scores_gemma":[0.002041987,0.000674572,0.0003288215,0.0001688788,0.00001550313,0.00007906501,0.00009244142,0.00002052025,0.9957712,0.00008382992,0.0006242917,0.00009884129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995083,0.0001844378,0.004134164,0.0002117971,0.00008904755,0.00007858835,0.00001828672,0.000002169332,0.0001984926],"genre_scores_gemma":[0.9980338,0.00002492503,0.001216608,0.00007928558,0.0005397964,0.000001840682,0.000003728291,0.00001162936,0.00008833873],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002950831,"threshold_uncertainty_score":0.3358288,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4292295879","doi":"10.1039/d2cs00387b","title":"Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders","year":2022,"lang":"en","type":"review","venue":"Chemical Society Reviews","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":224,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"FP7 People: Marie-Curie Actions; FP7 Ideas: European Research Council; Biotechnology and Biological Sciences Research Council; European Commission; Directorate for Biological Sciences; European Federation of Pharmaceutical Industries and Associations; Horizon 2020 Framework Programme; University of Dundee; H2020 Marie Skłodowska-Curie Actions; Innovative Medicines Initiative; McGill University","keywords":"DNA ligase; Ubiquitin ligase; Small molecule; Chemistry; Computational biology; Combinatorial chemistry; Biochemistry; Stereochemistry; Ubiquitin; DNA; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.05672681427050509,"gpt":0.2969829266204442,"spread":0.2402561123499391,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000581091,0.0005182003,0.001165112,0.00001731479,0.000161523,0.00008699669,0.0003352135,0.0004344073,0.000006990431],"category_scores_gemma":[0.000542976,0.000309863,0.001303177,0.0001771102,0.0003218094,0.0000137305,0.0004486439,0.0003964857,8.919628e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003983417,"about_ca_system_score_gemma":0.0001628449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001088988,"about_ca_topic_score_gemma":0.000001064506,"domain_scores_codex":[0.9980466,0.00008452675,0.0007838697,0.0006669402,0.0001251035,0.0002929133],"domain_scores_gemma":[0.9985501,0.0001898621,0.0005694687,0.0005399922,0.00004046712,0.0001101074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003879409,0.0001533635,0.000008490731,0.02247506,0.0005179775,5.150941e-7,0.0002756238,5.269231e-8,0.06841015,0.0000675377,0.02075233,0.8873001],"study_design_scores_gemma":[0.0002329618,0.0001092292,1.40587e-7,0.001422227,0.0002775667,0.00001543134,0.0000765458,0.000005877803,0.1424594,0.00001553583,0.8550744,0.000310666],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004941913,0.9912725,0.0001160671,0.0001040848,0.000094909,0.003314777,0.0001278678,0.00001003664,0.00001782513],"genre_scores_gemma":[0.0001329653,0.9965275,0.000257245,0.0003641577,0.0002844213,0.001352241,0.0006245067,0.0000649383,0.0003920473],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8869895,"threshold_uncertainty_score":0.9999353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2063887542","doi":"10.1021/jm200640v","title":"3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands","year":2011,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":223,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Knut och Alice Wallenbergs Stiftelse; Karolinska Institutet; Stiftelsen för Strategisk Forskning; Cancer Research UK; Ontario Genomics Institute; Canadian Institutes of Health Research; Ontario Genomics; Genome Canada; Ontario Innovation Trust; Wellcome Trust; GlaxoSmithKline","keywords":"Bromodomain; Acetylation; Chemistry; BRD4; Histone; Lysine; Epigenetics; Biochemistry; Chromatin; PHD finger; Histone Acetyltransferases; Transcription factor; Computational biology; Gene; Biology; Amino acid","retraction":null,"screen_n_in":null,"score":{"opus":0.01290468324358886,"gpt":0.2417098870984178,"spread":0.228805203854829,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005396327,0.000186696,0.0002647237,0.00004777332,0.00005444992,0.0000135503,0.0003594394,0.0002113747,0.0004555252],"category_scores_gemma":[0.0004590896,0.0001501649,0.0001993004,0.0001097158,0.0001435719,0.00001132213,0.00006793968,0.0003094676,0.00001328186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002584312,"about_ca_system_score_gemma":0.0002328802,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008712791,"about_ca_topic_score_gemma":6.762539e-7,"domain_scores_codex":[0.9986839,0.00003140838,0.0004910951,0.0001842547,0.0003876307,0.0002217003],"domain_scores_gemma":[0.998831,0.00001538194,0.0004188871,0.0002658134,0.000212163,0.0002567166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002793639,0.0001010208,0.000626187,0.00003730686,0.00009799792,0.00005675689,0.0001010378,0.000001122645,0.9910949,0.000007330268,0.005672308,0.001924625],"study_design_scores_gemma":[0.001019952,0.0005248517,0.0004798351,0.0000921202,0.00006854563,0.00087754,0.000262324,0.00000306954,0.9815792,0.0001833436,0.01474872,0.0001604396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853076,0.002201715,0.0003215663,0.0003094926,0.000224277,0.00005181718,0.000002454793,0.000007441774,0.01157359],"genre_scores_gemma":[0.9958032,0.0003423724,0.001018105,0.0003159836,0.001092311,0.000002221779,0.00001351378,0.00002169487,0.001390558],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01049559,"threshold_uncertainty_score":0.6123545,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3100577837","doi":"10.1182/blood.2020008676","title":"CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":221,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health; U.S. Department of Energy; International Development Research Centre; Office of Science; Government of Ontario; Bristol-Myers Squibb","keywords":"Cereblon; Ubiquitin ligase; Cancer research; Cell biology; Integrated stress response; Stem cell; Chemistry; Biology; Myeloid leukemia; Leukemia; Ubiquitin; Immunology; Biochemistry; Translation (biology)","retraction":null,"screen_n_in":null,"score":{"opus":0.009025599242421198,"gpt":0.202692558490278,"spread":0.1936669592478568,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007679405,0.0002604328,0.0002173541,0.00003271076,0.00009760963,0.00005547325,0.0002024627,0.0002347342,0.00001332937],"category_scores_gemma":[0.00002231616,0.0002556218,0.00009823206,0.0001115259,0.00008466678,0.00001160361,0.0002069211,0.0001596504,0.00003791845],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003125051,"about_ca_system_score_gemma":0.0001952283,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001453404,"about_ca_topic_score_gemma":0.000004058605,"domain_scores_codex":[0.9986469,0.00003179415,0.0002690641,0.0005667032,0.0001784676,0.0003071034],"domain_scores_gemma":[0.9992079,0.000006864863,0.0001135502,0.0003079661,0.00006193533,0.0003017469],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00005470517,0.0001615163,0.0001413364,0.00003401441,0.0001209771,0.00001256041,0.00008354142,0.00001594346,0.9946622,0.00004148277,0.003521529,0.001150251],"study_design_scores_gemma":[0.004799777,0.000317523,0.0001613932,0.00001581875,0.00007467296,0.00002797915,0.00003250409,0.0003619447,0.966111,0.000007885667,0.02778769,0.0003018179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965721,0.0009799611,0.001099522,0.0003013816,0.0001223913,0.0002939113,0.0000911957,0.00005088627,0.0004885895],"genre_scores_gemma":[0.9960488,0.0002804268,0.001117043,0.001218586,0.0004510435,0.00002367941,0.0000808787,0.00004367885,0.0007358363],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02855115,"threshold_uncertainty_score":0.9999896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2984431814","doi":"10.1093/jncics/pkz093","title":"Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors","year":2019,"lang":"en","type":"article","venue":"JNCI Cancer Spectrum","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":207,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health; GlaxoSmithKline","keywords":"Bromodomain; Medicine; Nut; Cancer research; Internal medicine; Biochemistry; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.009424531050998724,"gpt":0.2753434312589721,"spread":0.2659189002079734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001971393,0.0002110683,0.0002923073,0.0001058468,0.00003664401,0.00002583771,0.0001211396,0.0001068908,0.00007721555],"category_scores_gemma":[0.00001190217,0.0001989913,0.00003869063,0.0001217517,0.00008899516,0.00001333846,0.0001108259,0.0001265341,0.000002014282],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003625863,"about_ca_system_score_gemma":0.0001337337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007630641,"about_ca_topic_score_gemma":0.0007527194,"domain_scores_codex":[0.9986331,0.0001035938,0.0003426906,0.0004677065,0.0001746123,0.0002783296],"domain_scores_gemma":[0.999427,0.000005642552,0.0001512713,0.0003018381,0.00001926779,0.00009498142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000789345,0.0008151328,0.0828197,0.0001034736,0.00003670247,0.00003330456,0.0007321055,0.0000036831,0.9126902,0.0001845333,0.0002088091,0.001583032],"study_design_scores_gemma":[0.01190137,0.004854287,0.02018026,0.0001511762,0.00001696835,0.00004892242,0.001133268,0.0001414531,0.9584233,0.0003856078,0.002294072,0.0004692924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972438,0.0008926308,0.00001827234,0.0001466857,0.00008489981,0.001196606,0.00003303971,0.000008883769,0.0003751607],"genre_scores_gemma":[0.999045,0.00002221012,0.0001123966,0.00009800478,0.00018002,0.0001395546,0.000006450073,0.0000315462,0.0003648695],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06263944,"threshold_uncertainty_score":0.8114629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2604744033","doi":"10.1021/acs.jmedchem.6b01781","title":"A “Click Chemistry Platform” for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation","year":2017,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":204,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Discovery Centre","funders":"","keywords":"Linker; Bromodomain; Ubiquitin ligase; Chemistry; Ubiquitin; DNA ligase; Protein degradation; Target protein; Click chemistry; Ternary complex; Proteolysis; Native chemical ligation; Small molecule; Biochemistry; Ubiquitin-Protein Ligases; Cell biology; Combinatorial chemistry; Chemical synthesis; DNA; Biology; Enzyme; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.02649876102437507,"gpt":0.2790411026217938,"spread":0.2525423415974187,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008135929,0.0001598549,0.0002622082,0.00001927646,0.0002530072,0.000041585,0.0005849361,0.0001941151,0.00003783911],"category_scores_gemma":[0.003037228,0.000111833,0.0002563277,0.00002937219,0.0001925689,0.00001747875,0.00005516158,0.0001683937,2.007023e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002846139,"about_ca_system_score_gemma":0.0002214118,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004401738,"about_ca_topic_score_gemma":7.69939e-7,"domain_scores_codex":[0.9988058,0.00001127963,0.0005385084,0.0001776869,0.0002822166,0.0001845457],"domain_scores_gemma":[0.9977333,0.0001008765,0.001215505,0.0004545182,0.0004019763,0.00009380087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004652149,0.00004612495,0.00004896329,0.0002896934,0.000111074,0.000001230813,0.00001813892,0.000006253967,0.9776391,0.000009355211,0.002362336,0.01900254],"study_design_scores_gemma":[0.001048949,0.0001590028,0.0001119111,0.0002803855,0.00008685314,0.00005898587,0.0002962833,0.0001111176,0.9800857,0.00007736962,0.0175656,0.000117808],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980248,0.002107855,0.01411935,0.00174194,0.0002020602,0.0005374607,0.00005099216,0.000004636785,0.0009877257],"genre_scores_gemma":[0.9953063,0.0001812916,0.002521453,0.00004172192,0.001270036,0.00008056527,0.0000233449,0.0000230976,0.0005522119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01888473,"threshold_uncertainty_score":0.4560416,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2560915683","doi":"10.1021/jacs.6b11467","title":"Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations","year":2016,"lang":"en","type":"article","venue":"Journal of the American Chemical Society","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":201,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Structural Genomics Consortium; Engineering and Physical Sciences Research Council; Wellcome Trust; Wellcome","keywords":"Chemistry; Isothermal titration calorimetry; Affinities; Bromodomain; Binding affinities; Selectivity; Molecular dynamics; Computational chemistry; Ligand (biochemistry); Binding energy; Interaction energy; Free energy perturbation; Biological system; Stereochemistry; Molecule; Physical chemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.006635071517930045,"gpt":0.2259788436639183,"spread":0.2193437721459883,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009777022,0.00007065031,0.0001419511,0.000009926664,0.00005514767,0.000005657575,0.0002535594,0.00005406544,0.000007475691],"category_scores_gemma":[0.0002149402,0.00004035283,0.0003317847,0.0001417119,0.0002431541,0.000007218439,0.0001121596,0.00008159216,3.012994e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004304903,"about_ca_system_score_gemma":0.00007964246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006391307,"about_ca_topic_score_gemma":0.000004743935,"domain_scores_codex":[0.9993674,0.00003607077,0.0002322679,0.00009709093,0.0001657577,0.0001013852],"domain_scores_gemma":[0.9991091,0.00004037206,0.0004633336,0.0002165616,0.000113412,0.00005725601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002086161,0.00003725943,0.00202473,8.819305e-7,0.0001050661,6.313363e-8,0.00001649771,0.000006259362,0.9793831,0.00001134552,0.01746109,0.000932835],"study_design_scores_gemma":[0.000330561,0.00006141718,0.003446833,0.00002300967,0.00002972485,0.000006183504,0.00002809736,0.00003438104,0.9893258,0.0001935563,0.00646342,0.00005702607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889308,0.00008043611,0.009403476,0.00133634,0.00009740678,0.00002398329,0.00005713502,0.000003229691,0.00006717052],"genre_scores_gemma":[0.9976413,0.0001377164,0.001520137,0.0001736203,0.0003620945,0.0000015564,0.000003086454,0.000007929199,0.0001525954],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01099767,"threshold_uncertainty_score":0.1645541,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1966585118","doi":"10.1371/journal.pone.0083190","title":"RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":199,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Resverlogix (Canada)","funders":"Alberta Innovates","keywords":"Bromodomain; BRD4; Epigenetics; Apolipoprotein B; Inducer; BET inhibitor; Binding site; Chemistry; Acetylation; In vivo; Biology; Biochemistry; Cholesterol; Genetics; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.03025521576782595,"gpt":0.2369448331627485,"spread":0.2066896173949225,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008596487,0.00009535652,0.0001467258,0.00004953559,0.00002843321,0.00001753792,0.0001441899,0.0001245589,0.0002412775],"category_scores_gemma":[0.00003481335,0.00009463756,0.00003420429,0.0000738833,0.00005900378,0.000009590878,0.00005296164,0.00007580771,0.00003513727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000009680966,"about_ca_system_score_gemma":0.00003099405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001853408,"about_ca_topic_score_gemma":0.00005060999,"domain_scores_codex":[0.9992332,0.00004951806,0.0002040137,0.0002223465,0.0001400363,0.0001508108],"domain_scores_gemma":[0.9994935,0.000003186825,0.00006713266,0.0003111816,0.00006357066,0.00006140798],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000013776,0.0006686957,0.007681611,0.00002558934,0.00003244685,4.804798e-7,0.00009852996,1.713682e-7,0.9899341,0.00005600857,0.001150784,0.0003378234],"study_design_scores_gemma":[0.0004442476,0.0002430986,0.007302374,0.0000358413,0.00000894363,3.540129e-7,0.00006957631,0.00002407327,0.9907721,0.0001900504,0.0007854727,0.0001239068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997932,0.0001750096,0.00001790108,0.0003231161,0.00001740407,0.0002644805,0.00002080749,0.000007813203,0.001241434],"genre_scores_gemma":[0.9970387,0.00005362045,0.001492917,0.000402941,0.0001070602,0.00004590924,0.0001330937,0.00001551103,0.0007102342],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001475016,"threshold_uncertainty_score":0.3859208,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2096783705","doi":"10.1021/jm3010515","title":"Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit","year":2012,"lang":"en","type":"article","venue":"Journal of Medicinal Chemistry","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":196,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Wellcome Trust; Canadian Institutes of Health Research; Genome Canada; Novartis Foundation; GlaxoSmithKline; Ontario Ministry of Research and Innovation; Pfizer; Eli Lilly and Company","keywords":"Bromodomain; Acetylation; Histone Acetyltransferases; Chemistry; Histone; BRD4; Small molecule; Epigenetics; Chromatin; Biochemistry; Histone acetyltransferase; Lysine; Structure–activity relationship; Computational biology; In vitro; Amino acid; DNA; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01162130374228581,"gpt":0.2608740894839077,"spread":0.2492527857416219,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004213305,0.00009828819,0.0001968482,0.00002346832,0.00002033258,0.000005312761,0.00007476498,0.0001441401,0.000019063],"category_scores_gemma":[0.0002785539,0.00008810882,0.00008593067,0.00005162828,0.0001232701,0.00002617367,0.00002594069,0.00008693211,6.822835e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002214142,"about_ca_system_score_gemma":0.00006540187,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001185297,"about_ca_topic_score_gemma":4.973204e-8,"domain_scores_codex":[0.9989402,0.00002256235,0.0005892675,0.0001032416,0.0002240803,0.0001206396],"domain_scores_gemma":[0.9987908,0.0000174715,0.0007616951,0.000104337,0.0002460339,0.00007967722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002625959,0.0001401658,0.0002233543,0.0002979117,0.0000353506,7.094529e-7,0.0001505312,0.00001536223,0.9980133,0.0000115975,0.0002947391,0.0005543437],"study_design_scores_gemma":[0.001226975,0.0001885391,0.0001144349,0.0001554799,0.00006546611,0.0002257404,0.000197429,0.0001208042,0.9973437,0.00008611203,0.0001985597,0.00007674989],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9230072,0.001022153,0.07555346,0.0001524044,0.00006678332,0.0001342754,0.00001266529,0.00000176519,0.00004924119],"genre_scores_gemma":[0.9918156,0.000122534,0.007499119,0.00002737245,0.000429391,0.000008575119,0.00005440033,0.00001035664,0.00003260539],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0688084,"threshold_uncertainty_score":0.3592973,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2196777184","doi":"10.1039/c5sc03115j","title":"A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain","year":2015,"lang":"en","type":"article","venue":"Chemical Science","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":191,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Structural Genomics Consortium","funders":"Janssen Pharmaceuticals; Engineering and Physical Sciences Research Council; Ministero dello Sviluppo Economico; Swansea University; Worldwide Cancer Research; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; Takeda Pharmaceutical Company; European Federation of Pharmaceutical Industries and Associations; AbbVie; Wellcome; Merck; Fundação de Amparo à Pesquisa do Estado de São Paulo; Genome Canada; Novartis Pharma; Novartis; European Commission; Pfizer","keywords":"Bromodomain; Fragment (logic); Chemistry; Combinatorial chemistry; Stereochemistry; Computational biology; Biochemistry; Computer science; Biology; Epigenetics; Algorithm","retraction":null,"screen_n_in":null,"score":{"opus":0.02217427758218534,"gpt":0.2444993015377055,"spread":0.2223250239555202,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004983828,0.0001124169,0.0001106944,0.00003615871,0.000114208,0.00004317308,0.0004541571,0.0001021808,0.00002846766],"category_scores_gemma":[0.0005996432,0.00007602231,0.00005630369,0.0003113252,0.0006469264,0.00003335229,0.0002689857,0.00008912392,0.000002782693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002125677,"about_ca_system_score_gemma":0.0001994755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007630457,"about_ca_topic_score_gemma":8.943229e-7,"domain_scores_codex":[0.9987018,0.00003519468,0.0002714384,0.0003903894,0.0003665939,0.0002346408],"domain_scores_gemma":[0.999122,0.00001983389,0.0001178786,0.0004587948,0.00006799289,0.0002135296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006766271,0.00007197922,0.0003395309,0.000005989814,0.000003356996,0.00000164199,0.00009941862,0.000006825389,0.9959192,0.00008217463,0.001919505,0.001482748],"study_design_scores_gemma":[0.0002346075,0.0001272677,0.0001968509,0.00003610931,0.000005025271,0.00001424641,0.0001660602,0.0002219679,0.9913345,0.0002412131,0.007309909,0.0001122336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975514,0.0002271338,0.0002020712,0.0008843635,0.0001336201,0.0001725239,0.000002388862,0.00002185424,0.0008046224],"genre_scores_gemma":[0.9987321,0.00001946467,0.0007451237,0.0002595532,0.0001540172,0.00001592349,0.0000178648,0.000009567172,0.00004637328],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005390404,"threshold_uncertainty_score":0.31001,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2904329518","doi":"10.1016/j.molcel.2018.11.006","title":"Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains","year":2018,"lang":"en","type":"article","venue":"Molecular Cell","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":189,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Heart and Stroke Foundation; University of Toronto; SickKids Foundation; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Structural Genomics Consortium; National Institute of General Medical Sciences; Janssen Biotech; Canadian Institutes of Health Research; Innovative Medicines Initiative; Uehara Memorial Foundation; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; Medical Research Council; Cancer Research Society; Genome Canada; Boehringer Ingelheim; University of Toronto; Eesti Teadusagentuur; AbbVie; Merck; Pfizer; Natural Sciences and Engineering Research Council of Canada; Alfred P. Sloan Foundation","keywords":"Bromodomain; Interactome; BRD4; BET inhibitor; Biology; Computational biology; Protein–protein interaction; Chromatin; Plasma protein binding; Genetics; Acetylation; Gene; Cell biology","retraction":null,"screen_n_in":null,"score":{"opus":0.007724121999411446,"gpt":0.2632018455588547,"spread":0.2554777235594433,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001827664,0.0001247093,0.0001274951,0.00004310566,0.0000588902,0.00001417571,0.0001873721,0.0001036235,0.00007486997],"category_scores_gemma":[0.00008091978,0.0001203567,0.0001569363,0.00009601741,0.00007026159,0.000004817343,0.0001580156,0.00008393598,0.00002313188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001104332,"about_ca_system_score_gemma":0.00002676612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005211992,"about_ca_topic_score_gemma":7.797644e-7,"domain_scores_codex":[0.9990763,0.00007378868,0.0002287668,0.0002702839,0.0001374225,0.0002134578],"domain_scores_gemma":[0.9995952,0.000006521062,0.00009512019,0.0001693541,0.0000632409,0.00007051034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00002697475,0.00005023043,0.000430432,0.000008770415,0.00003206402,0.00001253856,0.00003249462,0.000005847733,0.9975313,0.00002146588,0.001251974,0.0005959218],"study_design_scores_gemma":[0.0004530524,0.0002450476,0.00006916704,0.00001183671,0.00001850036,0.000001804165,0.00002984119,0.00006852602,0.9806333,0.00003229664,0.01829829,0.0001383724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785112,0.0003776705,0.01078735,0.00004952414,0.0002718005,0.0001348545,0.000003673556,0.00001570689,0.009848276],"genre_scores_gemma":[0.9958451,0.00001138218,0.003271675,0.0003274434,0.0001855938,0.000008347356,0.00005153343,0.00002048669,0.0002784176],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01733398,"threshold_uncertainty_score":0.4908004,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2550348382","doi":"10.1182/blood.v106.11.2605.2605","title":"Stable Suppression of a Novel Oncogene, AHI-1, in Human Cutaneous T-Cell Leukemia Cells Normalizes Its Transforming Activity In Vitro and In Vivo and Aberrant Expression of AHI-1 Is Also Present in Leukemic Sezary Cells from Patients with Sezary Syndrome.","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"","keywords":"Biology; Autocrine signalling; Cell culture; Leukemia; Provirus; Gene knockdown; Molecular biology; RNA interference; Small hairpin RNA; Cancer research; Immunology; Gene; RNA; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.005937374710615574,"gpt":0.2053744587937163,"spread":0.1994370840831008,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001214864,0.0002153394,0.0003513126,0.0001762787,0.00002469966,0.000008967221,0.0001174455,0.0002198599,0.00001313879],"category_scores_gemma":[0.000005837943,0.0001965877,0.00003236547,0.0001333097,0.00005649667,0.00004509119,0.00009972955,0.0001669004,1.175288e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005429574,"about_ca_system_score_gemma":0.0000922564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009879487,"about_ca_topic_score_gemma":0.0006795016,"domain_scores_codex":[0.9986064,0.00007383959,0.0004453706,0.0004136292,0.0002019098,0.0002588126],"domain_scores_gemma":[0.999506,0.00002592507,0.0001713171,0.0002047631,0.00002544269,0.00006653932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006546628,0.001132628,0.008235828,0.0001403125,0.000008629983,0.00001380461,0.0003811591,0.0003173285,0.9886828,8.954001e-8,0.00002202228,0.0004107444],"study_design_scores_gemma":[0.007248095,0.0002475333,0.003038915,0.0003653793,0.00001310174,0.000006686483,0.00006225728,0.0005401354,0.9881557,0.000001678917,0.0001063421,0.0002141358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983332,0.0007122575,0.00001836594,0.000008561969,0.0000193826,0.0005680945,0.0002233925,0.00000350735,0.0001132303],"genre_scores_gemma":[0.9989137,0.0003445103,0.0005485747,0.00001853893,0.00001357787,0.00002410643,0.00005599783,0.00002136927,0.00005959843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006593432,"threshold_uncertainty_score":0.8016613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3015646212","doi":"10.1038/s41467-020-15290-0","title":"Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction","year":2020,"lang":"en","type":"article","venue":"Nature Communications","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":188,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SKiN Health","funders":"Congressionally Directed Medical Research Programs; National Center for Advancing Translational Sciences; Melanoma Research Alliance; National Cancer Institute; Yale University; U.S. Department of Health and Human Services; National Natural Science Foundation of China; U.S. Department of Defense","keywords":"Macrophage; Cancer research; Cancer; BRD4; Cancer cell; Chemistry; Cell biology; Bromodomain; Biology; Biochemistry; Genetics; Histone; DNA; In vitro","retraction":null,"screen_n_in":null,"score":{"opus":0.01838858552513328,"gpt":0.3020018338926679,"spread":0.2836132483675347,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004786149,0.000107564,0.0000824427,0.00001582542,0.0001537768,0.00003498774,0.0005366585,0.0002268527,0.00007773531],"category_scores_gemma":[0.0001249806,0.0001047609,0.00007026188,0.0001109592,0.00005486505,0.00001285802,0.000339986,0.000405783,0.00002413576],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002491603,"about_ca_system_score_gemma":0.00005862057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004534044,"about_ca_topic_score_gemma":0.0002060297,"domain_scores_codex":[0.9993423,0.00008307828,0.000164091,0.0002002786,0.00009779111,0.0001125038],"domain_scores_gemma":[0.9989656,0.00001553436,0.00008695736,0.0007112191,0.00012619,0.00009454972],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003669081,0.000103384,0.0004465172,0.00001448992,0.00002700949,4.543552e-7,0.0001096397,0.0000283034,0.8841705,0.0002458772,0.1117874,0.003029728],"study_design_scores_gemma":[0.0001647542,0.00004575555,0.000241346,0.000007057762,0.000009444416,0.000001129209,0.00009193187,0.0001491206,0.4873418,0.000003968639,0.5118521,0.00009161698],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6034544,0.1990785,0.002600175,0.1223954,0.003129617,0.002195782,0.0006743653,0.0004090658,0.06606276],"genre_scores_gemma":[0.9910617,0.003336396,0.00136742,0.003097039,0.0003364907,0.00006440441,0.0004090715,0.00001807609,0.0003093267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4000646,"threshold_uncertainty_score":0.4272025,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1932584694","doi":"10.1161/circresaha.115.307004","title":"Bromodomain-Containing Protein 4","year":2015,"lang":"en","type":"article","venue":"Circulation Research","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":186,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research","keywords":"Cancer research; Survivin; microRNA; BRD4; Downregulation and upregulation; Apoptosis; Cell cycle; Bromodomain; Cell growth; Chemistry; Cell biology; Epigenetics; Biology; Biochemistry; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.1437878241753064,"gpt":0.3854728962561591,"spread":0.2416850720808527,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001226383,0.00006506873,0.00005912274,0.00009513627,0.000110431,0.00005519862,0.0001382096,0.0001018874,0.00003551761],"category_scores_gemma":[0.0006423705,0.00006555809,0.00003270952,0.0002016811,0.00007829218,0.000007720211,0.00008832679,0.0001295805,0.0001202889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004273263,"about_ca_system_score_gemma":0.0002033659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004085633,"about_ca_topic_score_gemma":0.00001307883,"domain_scores_codex":[0.9987628,0.0002177641,0.0001337768,0.0002409233,0.0004083847,0.0002363867],"domain_scores_gemma":[0.9991474,0.00000840957,0.00002893518,0.0002785393,0.0003842152,0.0001525199],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001434604,0.00006336779,0.01010591,0.00001352353,0.00002106955,0.000005567043,0.0001630209,0.0004005286,0.9678761,0.003837719,0.01096928,0.006400446],"study_design_scores_gemma":[0.003544159,0.001159097,0.02380157,0.00007038742,0.00000574814,0.00003579118,0.001323896,0.004171338,0.7065879,0.008756245,0.2498809,0.00066304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9801038,0.0002187932,0.002997263,0.0004052995,0.00006347387,0.0004069761,0.000001784059,0.00001981874,0.01578283],"genre_scores_gemma":[0.9973966,0.000002321846,0.0004025372,0.00005475726,0.0002855622,0.00007220976,0.00007843408,0.00001467801,0.001692895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2612883,"threshold_uncertainty_score":0.2673381,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1951559178","doi":"10.1016/j.molcel.2015.09.002","title":"EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling","year":2015,"lang":"en","type":"article","venue":"Molecular Cell","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":185,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mental Health Research Canada; Hospital for Sick Children; University Health Network","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Biology; Epigenome; Epigenetics; Transcription factor; Cancer research; Epidermal growth factor receptor; Bromodomain; Carcinogenesis; Transcriptome; Enhancer; Genetics; Mutation; DNA methylation; Gene; Gene expression; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.01643594838255873,"gpt":0.2331048341559888,"spread":0.2166688857734301,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001195303,0.0001472166,0.0001044173,0.00002326593,0.00006237918,0.00003984764,0.00007975024,0.0001362349,0.000007263593],"category_scores_gemma":[0.00003017807,0.0001338775,0.00005473291,0.00008668333,0.00003817182,0.00001260339,0.00003505577,0.00007352897,0.00001183555],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001788247,"about_ca_system_score_gemma":0.00004724466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001411366,"about_ca_topic_score_gemma":0.000008227525,"domain_scores_codex":[0.9990835,0.00007454983,0.0001786262,0.0003077819,0.0001463277,0.0002092168],"domain_scores_gemma":[0.9995495,0.000002467835,0.00006493412,0.0001936911,0.00008792363,0.0001014923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00006303028,0.00003053639,0.00009119296,0.00001804107,0.00001238252,0.000007941833,0.0002373152,0.0008320591,0.9951597,0.00006905104,0.0003817175,0.003097004],"study_design_scores_gemma":[0.0006519089,0.0004172959,0.00003888276,0.00001216963,0.00001388739,0.000009813201,0.00007445495,0.0007372504,0.9684397,0.0008812851,0.02850452,0.0002188144],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8848808,0.002668848,0.1102909,0.0001938356,0.0001625158,0.0002944545,0.000006626027,0.00002963316,0.001472388],"genre_scores_gemma":[0.9933971,0.00006166648,0.005600112,0.0002965856,0.000165109,0.00001528124,0.00009786418,0.00002766776,0.0003385721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1085164,"threshold_uncertainty_score":0.5459367,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100150541","doi":"10.1101/gad.223396.113","title":"Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity","year":2013,"lang":"en","type":"article","venue":"Genes & Development","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":183,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Université Laval; Hôtel-Dieu de Québec","funders":"National Institute of General Medical Sciences; National Institute for Health and Care Research; Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs; Compute Canada","keywords":"Biology; Histone acetyltransferase; Chromatin; Histone Acetyltransferases; Protein subunit; Acetyltransferase; Histone; Chromatin remodeling; Histone H4; Histone H1; Cell biology; Histone octamer; Histone H3; Genetics; Acetylation; Nucleosome; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01438632752042767,"gpt":0.2347214120253747,"spread":0.220335084504947,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001579984,0.000163913,0.0001860658,0.00007858951,0.00004469353,0.00001126962,0.0001392024,0.0001376427,0.0002222272],"category_scores_gemma":[0.00005069572,0.0001527255,0.00005151399,0.0001501389,0.00003554663,0.000006537284,0.00006239492,0.0000611299,0.00002278963],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008187601,"about_ca_system_score_gemma":0.0001273804,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001950178,"about_ca_topic_score_gemma":0.0004291669,"domain_scores_codex":[0.9989265,0.00005303089,0.0003293645,0.0002707873,0.0001760449,0.0002442353],"domain_scores_gemma":[0.9995553,0.00000756446,0.000083472,0.0001764753,0.00009943292,0.00007772468],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00001885843,0.0001938139,0.02897674,0.00002827858,0.0000459864,0.000001421212,0.0005698593,0.000004943664,0.9506624,0.000007872183,0.002833709,0.01665616],"study_design_scores_gemma":[0.000398719,0.00004336577,0.1060106,0.00001949456,0.000002949262,4.93876e-7,0.0001033883,0.000003884314,0.8615686,0.00000890903,0.03165851,0.0001810933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975291,0.001000217,0.0002059392,0.0001323292,0.0001548105,0.0003458374,0.000007403383,0.00001422162,0.0006101719],"genre_scores_gemma":[0.9974567,0.0002992848,0.0006790123,0.00009683597,0.00003433981,0.00007576006,0.0002045979,0.00001662424,0.001136829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08909377,"threshold_uncertainty_score":0.6227964,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4364356934","doi":"10.1021/acscentsci.2c01317","title":"Rational Chemical Design of Molecular Glue Degraders","year":2023,"lang":"en","type":"article","venue":"ACS Central Science","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":183,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Division of Chemistry; Natural Sciences and Engineering Research Council of Canada; Mark Foundation For Cancer Research; Innovative Genomics Institute; Novartis Institutes for BioMedical Research; National Cancer Institute; National Institutes of Health; National Science Foundation","keywords":"Computational biology; Chemistry; Ubiquitin; Ubiquitin ligase; Covalent bond; Target protein; Proteasome; Protein degradation; Biochemistry; Combinatorial chemistry; Biology; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.01631584461292817,"gpt":0.2541396342241705,"spread":0.2378237896112423,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002168245,0.00006092287,0.00005039621,0.00004155407,0.00005366535,0.00001552273,0.0002524468,0.00004397058,0.00001087435],"category_scores_gemma":[0.0002247958,0.00005605029,0.00002927166,0.0004360842,0.0003102739,0.000008250173,0.00007600141,0.00003355045,0.00001177151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000129381,"about_ca_system_score_gemma":0.0001879313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003886821,"about_ca_topic_score_gemma":2.589636e-7,"domain_scores_codex":[0.9991422,0.00001947264,0.0001109666,0.0002156939,0.000256301,0.0002553813],"domain_scores_gemma":[0.9996607,0.000006446738,0.00003791214,0.0001470506,0.00006104597,0.00008681119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000008092949,0.00001126278,0.0002806074,0.000001949186,0.00000271572,9.810075e-7,0.00001683122,0.0003780103,0.9965951,0.0007147489,0.001288786,0.0007009495],"study_design_scores_gemma":[0.0001218463,0.00003581365,0.001367154,0.000003520794,0.000001784236,0.00000233641,0.00002143137,0.0005579893,0.9968168,0.0001532583,0.0008481537,0.00006995036],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988974,0.00005460078,0.01012854,0.0003290401,0.0001176818,0.0001297606,0.000004070036,0.00001578944,0.0002465607],"genre_scores_gemma":[0.9979368,0.00002582587,0.001731808,0.0001383826,0.00003981055,0.000006534147,0.0000298139,0.000004365236,0.00008658511],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008962918,"threshold_uncertainty_score":0.2285665,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}